[{"text": "Cognition Therapeutics CEO Participating in Longwood and Sachs Conferences Cognition Therapeutics, Inc. Thu, Jan 9, 2025, 12:14 AM 2 min read In This Article: CGTX Cognition Therapeutics, Inc. PURCHASE, N.Y., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , (the \u201cCompany\u201d or \u201cCognition\u201d) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that CEO Lisa Ricciardi will be participating at upcoming conferences taking place during the week of the JP Morgan Healthcare Conference 2025. \u201cI am looking forward to these opportunities to discuss the incredible progress we have made in 2024 with our Alzheimer\u2019s and dementia with Lewy body (DLB) programs,\u201d stated Ms. Ricciardi. \u201cWe capped off 2024 with positive topline results from our Phase 2 SHIMMER study in patients with DLB and are looking forward to presenting these findings at the International Lewy Body Dementia Conference at the end of January in Amsterdam. We are preparing now for our end-of-Phase 2 meeting with the FDA to review results from our SHINE study in mild-to-moderate Alzheimer\u2019s disease, an important regulatory milestone. In addition, we received clearance for the generic name for our candidate, CT1812, which will be called zervimesine.\u201d Presentation Details: Longwood Healthcare Leaders Stanford Summit Dates: January 11, 2025 Panel (moderator): Accelerating Drug Development Location: The Four Seasons, San Francisco, CA Sachs 8th Annual Neuroscience Innovation Forum Date: January 12, 2025 Panel: Innovation in AD/PD & Other Cognitive Disorders Panel Corporate Presentation: 1:40 PM Track C Heritage Room Location: Marines\u2019 Memorial Club, San Francisco, CA About Cognition Therapeutics, Inc. Cognition Therapeutics, Inc. , is a clinical-stage biopharmaceutical company discovering and developing innovative, small molecule therapeutics targeting age-related degenerative disorders of the central nervous system and retina. We currently are investigating our lead candidate, zervimesine (formerly CT1812) in clinical programs in Alzheimer\u2019s disease, dementia with Lewy bodies (DLB) and dry age-related macular degeneration (dry AMD). We believe zervimesine and our pipeline of \u03c3-2 receptor modulators can regulate pathways that are impaired in these diseases that are functionally distinct from other approaches for the treatment of degenerative diseases. More about Cognition Therapeutics and our pipeline can be found at https://cogrx.com . Forward-Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this press release, other than statements of historical facts or statements that relate to present facts or current conditions, including but not limited to, statements regarding our product candidates, including zervimesine (formerly CT1812), and any expected or implied benefits or results, including that initial clinical results observed with respect to zervimesine will be replicated in later trials and our clinical development plans, are forward-looking statements. These statements, including statements relating to the timing and expected results of our clinical trials involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as \u201cmay,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201cplan,\u201d \u201caim,\u201d \u201cseek,\u201d \u201canticipate,\u201d \u201ccould,\u201d \u201cintend,\u201d \u201ctarget,\u201d \u201cproject,\u201d \u201ccontemplate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cforecast,\u201d \u201cpotential\u201d or \u201ccontinue\u201d or the negative of these terms or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond our control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: competition; our ability to secure new (and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our management and key employees; our ability to successfully advance our current and future product candidates through development activities, preclinical studies and clinical trials and costs related thereto; uncertainties inherent in the results of preliminary data, pre-clinical studies and earlier-stage clinical trials being predictive of the results of early or later-stage clinical trials; the timing, scope and likelihood of regulatory filings and approvals, including regulatory approval of our product candidates; changes in applicable laws or regulations; the possibility that the we may be adversely affected by other economic, business or competitive factors, including ongoing economic uncertainty; our estimates of expenses and profitability; the evolution of the markets in which we compete; our ability to implement our strategic initiatives and continue to innovate our existing products; our ability to defend our intellectual property; impacts of ongoing global and regional conflicts on our business, supply chain and labor force; our ability to maintain the listing of our common stock on the Nasdaq Global Market and the risks and uncertainties described more fully in the \u201cRisk Factors\u201d section of our annual and quarterly reports filed with the\u00a0Securities & Exchange Commission and are available at www.sec.gov . These risks are not exhaustive and we face both known and unknown risks. You should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in a dynamic industry and economy. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties that we may face. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Story Continues Contact Information: Cognition Therapeutics, Inc. info@cogrx.com Casey McDonald (media) Tiberend Strategic Advisors, Inc. cmcdonald@tiberend.com Mike Moyer (investors) LifeSci Advisors mmoyer@lifesciadvisors.com This press release was published by a CLEAR\u00ae Verified individual. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2025-01-09T00:14:00", "sentiment": {"score": 0.12544854171574116, "confidence": 0.13733945786952972, "probabilities": {"positive": 0.13733945786952972, "negative": 0.011890916153788567, "neutral": 0.8507696390151978}}, "embedding": [-0.13918283581733704, -0.10911509394645691, -0.0005903886631131172, -0.02683924324810505, -0.08167298883199692, -0.01845591701567173, -0.056448254734277725, 0.1438705325126648, 0.04296546429395676, 0.016911756247282028, -0.07982030510902405, 0.0823930874466896, 0.021992065012454987, 0.10592371225357056, 0.02121838927268982, 0.13310810923576355, -0.021816451102495193, 0.017512090504169464, -0.0893871933221817, 0.06558845937252045, 0.018657851964235306, 0.06715437024831772, 0.045443251729011536, 0.06342990696430206, -0.1719282865524292, 0.03980831056833267, -0.11767160892486572, -0.20184335112571716, -0.08899694681167603, 0.009731307625770569, 0.13124549388885498, 0.17767933011054993, -0.1001114547252655, -0.04591938108205795, 0.01791667751967907, -0.04782239347696304, -0.1506425142288208, 0.02531880885362625, -0.10445830225944519, -0.11327137053012848, -0.0315961055457592, -0.030129272490739822, -0.10910254716873169, 0.06359726190567017, -0.01116919331252575, -0.17089423537254333, -0.015563899651169777, -0.03450772911310196, -0.06647038459777832, 0.001825183629989624, -0.08366835117340088, -0.09096436202526093, 0.014049379155039787, 0.10310124605894089, 0.003737789113074541, 0.16833145916461945, -0.18034031987190247, -0.10765008628368378, 0.030756769701838493, 0.03502865135669708, -0.08607217669487, -0.0558660551905632, 0.056677307933568954, -0.08590462803840637, 0.02249206230044365, 0.03509281948208809, 0.04298029839992523, -0.015875177457928658, 0.012040890753269196, -0.17166197299957275, -0.0045560309663414955, -0.062628373503685, 0.013611086644232273, 0.11216052621603012, 0.13737697899341583, 0.14106664061546326, 0.11417340487241745, 0.11088024079799652, 0.1582549810409546, -0.29568469524383545, 0.08953824639320374, 0.06567350029945374, 0.13404153287410736, -0.021558966487646103, 0.1792755275964737, -0.002846579300239682, 0.028081238269805908, 0.18497318029403687, 0.014089401811361313, -0.04939567670226097, 0.02301667630672455, -0.1433306336402893, -0.07070527970790863, -0.007207467220723629, -0.10084875673055649, -0.08016648143529892, -0.0059470245614647865, 0.06919173151254654, 0.01725240796804428, 0.05207093805074692, 0.029748529195785522, 0.0843890979886055, -0.036248303949832916, -0.06403303146362305, -0.09264159202575684, -0.05553320795297623, 0.13857285678386688, 0.07855318486690521, 0.07805100828409195, 0.04574819654226303, 0.0027741389349102974, 0.01187329925596714, 0.003262178972363472, 0.04443850740790367, -0.13020843267440796, 0.11871311068534851, -0.10913290083408356, 0.06501150876283646, 0.24043555557727814, -0.08588866889476776, 0.11958342790603638, 0.06525243818759918, 0.049915678799152374, -0.012005949392914772, -0.009574642404913902, 0.15076571702957153, -0.16262412071228027, 6.57836687294495e-33, -0.15039978921413422, 0.056683748960494995, 0.019062280654907227, 0.09176212549209595, 0.0718533843755722, -0.091208316385746, -0.02352563850581646, 0.006503558252006769, -0.10135941207408905, -0.1232481598854065, -0.11130031943321228, -0.015601991675794125, 0.033616021275520325, 0.2145681381225586, -0.08351410180330276, -0.06563429534435272, -0.06187686324119568, -0.012081503868103027, 0.002545473165810108, -0.09477311372756958, 0.027028366923332214, 0.09985682368278503, -0.06786762177944183, 0.08825480937957764, 0.024686340242624283, 0.04597581550478935, -0.08792521059513092, 0.04623067378997803, 0.08790508657693863, 0.10372202843427658, -0.17941853404045105, -0.049100376665592194, 0.031163640320301056, -0.05975247174501419, -0.057095907628536224, 0.049241047352552414, -0.030034352093935013, -0.17742043733596802, -0.041328977793455124, -0.01335352286696434, 0.06964996457099915, 0.0670982301235199, -0.16967996954917908, 0.0375693216919899, -0.041848331689834595, -0.04120126739144325, 0.10080528259277344, 0.06611195206642151, -0.031939875334501266, -0.06422097980976105, -0.058448344469070435, -0.07192996144294739, -0.08225470781326294, 0.006410055793821812, -0.08108044415712357, 0.11956053972244263, -0.10218428075313568, -0.06547904014587402, 0.17739054560661316, 0.055946044623851776, 0.1256197988986969, 0.19433535635471344, -0.14548340439796448, 0.024627309292554855, 0.021761946380138397, 0.058706045150756836, -0.006846451200544834, 0.01470525935292244, -0.11145990341901779, 0.04831398278474808, 0.0596747025847435, -0.08763495832681656, 0.15640729665756226, 0.13277515769004822, 0.11656741797924042, -0.05537351965904236, 0.16543391346931458, 0.03434059023857117, -0.009950889274477959, -0.110138900578022, 0.03993801772594452, 0.025081276893615723, -0.09185025840997696, 0.1363648623228073, 0.0313575342297554, -0.04064656421542168, 0.09386888146400452, -0.03036847710609436, -0.2392178475856781, 0.0046868957579135895, 0.054913461208343506, 0.018895026296377182, 0.0722394734621048, 0.1800042688846588, -0.13377562165260315, -9.249192893768884e-33, -0.07775577157735825, 0.016855375841259956, 0.022622914984822273, -0.0971231609582901, 0.021269679069519043, 0.05112869292497635, 0.04761020094156265, -0.16816383600234985, 0.09262587130069733, -0.32593029737472534, 0.1657569259405136, -0.027704423293471336, -0.05502695590257645, -0.0021271035075187683, -0.004855765029788017, 0.06328701972961426, -0.08942976593971252, -0.051494378596544266, -0.09170983731746674, 0.03132843226194382, 0.022046243771910667, 0.2297762781381607, -0.17935243248939514, 0.07156948745250702, -0.02095148339867592, 0.030700556933879852, 0.14368997514247894, 0.08280014991760254, 0.06638716161251068, 0.043324511498212814, -0.21760055422782898, 0.05302979052066803, -0.19681879878044128, -0.06914670020341873, -0.03957761079072952, 0.02851215936243534, 0.10422293841838837, -0.21302273869514465, -0.19511109590530396, -0.07751356065273285, 0.04280693084001541, 0.03135853260755539, -0.012168576940894127, 0.09053674340248108, 0.027999375015497208, 0.04436872527003288, 0.037651367485523224, -0.021278560161590576, 0.04901726543903351, 0.06394023448228836, -0.03225488215684891, -0.053909286856651306, -0.07202109694480896, -0.03904348611831665, -0.1359865814447403, -0.021957702934741974, 0.03750737011432648, -0.11188438534736633, -0.04152953252196312, -0.07673731446266174, -0.015313314273953438, 0.07437769323587418, 0.036919087171554565, -0.050438836216926575, 0.17349466681480408, 0.06708580255508423, 0.0751318484544754, 0.09242595732212067, -0.05591953545808792, -0.05567047372460365, 0.008984608575701714, -0.020851347595453262, -0.11102774739265442, -0.07590241730213165, 0.014290041290223598, 0.05109982192516327, -0.06943325698375702, -0.08637036383152008, -0.10112327337265015, -0.11688043177127838, -0.010185899212956429, 0.0032117171213030815, -0.03319821506738663, 0.059714868664741516, 0.07497158646583557, 0.04756322503089905, 0.005433768965303898, 0.0731138214468956, 0.031627871096134186, -0.027995828539133072, -0.08934202790260315, -0.10290975868701935, -0.07614898681640625, 0.08975512534379959, -0.07180124521255493, -1.0063889988032315e-07, 0.07326959818601608, -0.010926234535872936, -0.058761198073625565, -0.1149897649884224, 0.034667301923036575, -0.05140446498990059, -0.07281196117401123, 0.10983624309301376, -0.07521089166402817, 0.14855968952178955, 0.07866153120994568, 0.19054122269153595, -0.08520548045635223, -0.018409311771392822, -0.08959822356700897, 0.10018394887447357, -0.10584224760532379, 0.11703380942344666, -0.09891124814748764, -0.15379442274570465, -0.06710432469844818, 0.06703795492649078, 0.13487103581428528, -0.062499769032001495, 0.06537538766860962, -0.13282854855060577, 0.04970189183950424, 0.12605160474777222, -0.038081735372543335, -0.21458208560943604, -0.05070977658033371, 0.10695476830005646, -0.02570115402340889, 0.019415494054555893, 0.07186685502529144, -0.19429291784763336, 0.06907683610916138, 0.05098867416381836, 0.026175208389759064, 0.14819222688674927, 0.00974952895194292, -0.04440944641828537, -0.015531795099377632, 0.027848640456795692, 0.0634678304195404, -0.052857425063848495, 0.04053131118416786, 0.019461076706647873, 0.01197067741304636, -0.001927623525261879, -0.019745370373129845, 0.07753418385982513, 0.0547255203127861, -0.03314419090747833, -0.1134534627199173, 0.08377383649349213, -0.11690586805343628, 0.03078848496079445, -0.018835455179214478, -0.13819964230060577, 0.15408922731876373, 0.010450219735503197, 0.11859387159347534, 0.03028947114944458], "changes": {"1wk": -10.165182117182733}}, {"text": "Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations Aspira Women's Health Fri, Jan 10, 2025, 4:00 PM 6 min read In This Article: AWH Aspira Women's Health Inc. (\"Aspira\" or the \"Company\") (Nasdaq:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of Mike Buhle as SVP of Commercial Operations. Mr. Buhle has over 25 years of experience driving commercial growth and new product launches in the diagnostics and life science tools domains, working for start-up, scale-up, and established businesses. He brings hands-on leadership experience in clinical diagnostics specializing in precision medicine and patient outcomes in oncology, rare diseases, infectious diseases, and drug development and preventative interventions. Prior to joining Aspira, Mr. Buhle served as Chief Commercial Officer at Biovision Diagnostics and Vice President of Sales, Americas for Congenica. \"I am excited and honored to join Aspira Women's Health and look forward to leading such a dedicated and passionate commercial team,\" said Mike Buhle, Aspira's SVP of Commercial Operations. \"Together, we will continue to build on the momentum established, driving growth, and creating new opportunities. I believe that Aspira is poised for an outstanding year, not only in expanding market share for our current portfolio but also in achieving the key milestones required for the successful launch of our upcoming product pipeline.\" \"We are pleased to welcome Mike to the Aspira management team,\" said Dr. Sandra Milligan, Interim Chief Executive Officer of Aspira Women's Health. \"Mike's commercial experience and deep understanding of the micro-cap, life sciences industry will be immediately beneficial to Aspira, and we look forward to his commercial expertise and guidance to help take us through our next phase of growth.\" Separately, Interim Chief Financial Officer John Kallassy will be leaving the Company on January 10, 2025, to pursue other business opportunities. In his place, the Company has retained Mr. James O'Brien as CFO advisor. Mr. O'Brien brings over 30 years of experience in the biotechnology, pharmaceutical, and medical device industries. Over the short term, he will assist the Company in strategic initiatives, business development, and financial matters. Mr. O'Brien is the founder of Great Island Advisors LLC, a firm dedicated to leading and growing public and privately held businesses. Previously, he served as Chief Financial Officer of Faron Pharmaceuticals Ltd. (FARON), a clinical stage biotechnology company focused on oncology and immunotherapies. Mr. O'Brien also served as the inaugural Chief Financial Officer of Cognition Therapeutics, Inc. (CGTX), a clinical stage biopharmaceutical company which successfully completed an initial public offering in October 2021, raising $52 million. Earlier in his career, he held positions at pharmaceutical companies including Actavis PLC (now AbbVie, Inc. (ABBV)), the US subsidiary of Swiss company Nycomed Pharma S.A., which has since been acquired by Takeda Pharmaceutical Company Limited, and The Bristol Myers Squibb Company. He spent close to a decade at PricewaterhouseCoopers and is a certified public accountant (CPA) with a Bachelor of Accountancy degree from George Washington University and a Master of Business Administration degree from Fordham University. Story Continues Mike Buhle and Jim O'Brien will be joining interim CEO, Dr. Sandra Milligan for meetings during the JP Morgan Healthcare Conference week beginning on January 13 th in San Francisco, CA. About Aspira Women's Health Inc. Aspira Women's Health Inc. is dedicated to the discovery, development, and commercialization of noninvasive, AI-enabled tests to aid in the diagnosis of gynecologic diseases. OvaWatch\u00ae and Ova1Plus\u00ae are offered to clinicians as OvaSuite SM . Together, they provide the only comprehensive portfolio of blood tests to aid in the detection of ovarian cancer risk for the more than 1.2 million American women diagnosed with an adnexal mass each year. OvaWatch provides a negative predictive value of 99% and is used to assess ovarian cancer risk for women where initial clinical assessment indicates the mass is indeterminate or benign, and thus surgery may be premature or unnecessary. Ova1Plus is a reflex process of two FDA-cleared tests, Ova1\u00ae and Overa\u00ae, to assess the risk of ovarian malignancy in women with an adnexal mass planned for surgery. Our in-development test pipeline will expand our ovarian cancer portfolio and address the need for non-invasive diagnostics for endometriosis, a debilitating disease that impacts millions of women worldwide. In ovarian cancer, we intend to combine microRNA and protein biomarkers with patient data to further enhance the sensitivity and specificity of our current tests and expand the indicated population to screen women with a family history of ovarian cancer or a germline mutation. Through our ongoing endometriosis development program, we are combining microRNA and protein biomarkers with patient data, with the intent of identifying endometriosis independent of disease location or severity. Forward-Looking Statements This press release contains forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties. Such forward-looking statements include statements regarding, among other things, the timing and completion of any products in the development pipeline and other statements that are predictive in nature, and whether the marketing of the OvaSuite portfolio will prove successful. Actual results could differ materially from those discussed due to known and unknown risks, uncertainties, and other factors. These forward-looking statements generally can be identified by the use of words such as \"designed to,\" \"expect,\" \"plan,\" \"anticipate,\" \"could,\" \"may,\" \"intend,\" \"will,\" \"continue,\" \"future,\" and other words of similar meaning and the use of future dates. These and additional risks and uncertainties are described more fully in the Company's filings with the Securities and Exchange Commission (SEC), including those factors identified as \"Risk Factors\" in our most recent Annual Report on Form 10-K, for the fiscal year ended December 31, 2023, and subsequent Quarterly Reports on Form 10-Q. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Aspira presently does not know, or that Aspira currently believes are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Aspira's expectations, plans, or forecasts of future events and views as of the date of this press release. Subsequent events and developments may cause the Company's assessments to change. However, while Aspira may elect to update these forward-looking statements at some point in the future, Aspira expressly disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Aspira's assessments of any date after the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements. Investor Relations Contact: Mike Cavanaugh ICR Healthcare mike.cavanaugh@icrhealthcare.com SOURCE: Aspira Women's Health View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2025-01-10T16:00:00", "sentiment": {"score": 0.44017341546714306, "confidence": 0.4507009983062744, "probabilities": {"positive": 0.4507009983062744, "negative": 0.010527582839131355, "neutral": 0.5387714505195618}}, "embedding": [-0.12640200555324554, -0.08240510523319244, -0.16845175623893738, 0.0761166363954544, -0.07016066461801529, 0.0017272050026804209, 0.013882696628570557, 0.06401628255844116, 0.06883446127176285, -0.022412464022636414, -0.07313920557498932, -0.053233303129673004, -0.0485738180577755, 0.03651376813650131, -0.05966256558895111, -0.025493739172816277, 0.025795750319957733, -0.10090687870979309, -0.09245532751083374, 0.08674369752407074, 0.05535541847348213, 0.013863316737115383, 0.030647557228803635, 0.03871968388557434, -0.090408556163311, -0.06461827456951141, -0.09977835416793823, -0.07125858217477798, -0.13693465292453766, -0.18173719942569733, 0.022829154506325722, 0.09495717287063599, 0.1526397317647934, 0.0038849087432026863, 0.09140919148921967, 0.05859915167093277, -0.06319795548915863, 0.022707901895046234, -0.021875709295272827, 0.006684587337076664, 0.03568543121218681, -0.13978993892669678, -0.1266474425792694, -0.03532494604587555, 0.03601031005382538, -0.20467136800289154, 0.016620151698589325, -0.043527111411094666, 0.11319506913423538, 0.1253983974456787, -0.22556598484516144, -0.12194755673408508, -0.016333667561411858, 0.06015618145465851, -0.07182063162326813, 0.08533523976802826, -0.04154901206493378, -0.16959217190742493, -0.05560542270541191, -0.04852118715643883, 0.03601393848657608, -0.052151747047901154, 0.03292620927095413, 0.1127934455871582, 0.10683968663215637, -0.023839738219976425, -0.032447490841150284, -0.056397274136543274, -0.021067755296826363, -0.05850532650947571, 0.09935168921947479, -0.12703333795070648, -0.08911094069480896, 0.2303135246038437, 0.061748433858156204, 0.2051408588886261, 0.12285514175891876, 0.09523096680641174, 0.17097032070159912, -0.0580664798617363, 0.14351347088813782, -0.002880030544474721, 0.008656945079565048, 0.07214083522558212, -0.0679008811712265, 0.03589130938053131, -0.040082771331071854, 0.03064962849020958, 0.003398751839995384, -0.006222696974873543, -0.010035371407866478, -0.035587675869464874, 0.04900912195444107, -0.0020418954081833363, 0.02888632006943226, 0.028791118413209915, -0.026236077770590782, -0.06641489267349243, 0.08827217668294907, 0.03736960142850876, -0.20453734695911407, 0.020994005724787712, -0.03705631569027901, 0.034342337399721146, -0.11261395364999771, -0.11286947131156921, 0.019277870655059814, -0.06750459223985672, 0.06971108913421631, 0.007837534882128239, -0.02388659492135048, -0.007954131811857224, -0.0555386021733284, -0.03438332676887512, 0.05446651577949524, 0.17407411336898804, -0.06248703598976135, 0.012186512351036072, 0.1525300145149231, -0.13132378458976746, 0.015344412997364998, -0.020872507244348526, -0.014041082002222538, -0.0571441650390625, 0.1524151712656021, 0.12764999270439148, -0.12885886430740356, 5.5379805367283144e-33, 0.01991342566907406, 0.014148948714137077, 0.1802504062652588, 0.010391082614660263, -0.059544265270233154, 0.109821617603302, 0.04753311350941658, -0.10093319416046143, 0.010382508859038353, -0.19733864068984985, -0.11013954877853394, 0.0984804779291153, -0.021403227001428604, -0.043067850172519684, -0.07462163269519806, -0.09982071816921234, -0.007165977731347084, 0.05677463114261627, -0.14342756569385529, 0.046948909759521484, 0.051180269569158554, -0.020094260573387146, -0.0882236510515213, 0.09245552122592926, 0.0398537740111351, 0.02929782122373581, -0.055249009281396866, 0.05893600732088089, 0.025168055668473244, 0.03782618045806885, -0.024098286405205727, 0.09957098215818405, -0.1088545024394989, -0.15899860858917236, -0.0029568132013082504, -0.09094992280006409, -0.20359086990356445, -0.06416409462690353, -0.018597524613142014, 0.0777406096458435, -0.10072685778141022, 0.006598592735826969, -0.03239194303750992, -0.04784736409783363, -0.022211426869034767, -0.02895429916679859, -0.0378485731780529, 0.0728224366903305, 0.1487904042005539, -0.06292042136192322, -0.12236929684877396, -0.009136944077908993, 0.015388408675789833, -0.00971712451428175, 0.0637088194489479, 0.02247866615653038, -0.006501493975520134, -0.10304176807403564, 0.04800140857696533, 0.15323276817798615, 0.021571997553110123, 0.08568122982978821, -0.06249372661113739, 0.1157517209649086, -0.12499357014894485, -0.003686225973069668, 0.03574308753013611, 0.03881556913256645, -0.020025622099637985, 0.1288154572248459, -0.021442916244268417, -0.013365083374083042, 0.1260061115026474, 0.006025104783475399, 0.0248497873544693, 0.02937542274594307, -0.02195662260055542, 0.13697880506515503, -0.029942143708467484, 0.01795949786901474, 0.015544927679002285, 0.05266560614109039, 0.01683443784713745, 0.11604651808738708, 0.04469519108533859, -0.023380067199468613, 0.05379157513380051, -0.010566825047135353, -0.009960304945707321, 0.010636850260198116, -0.0007759081199765205, -0.002452364657074213, 0.053636617958545685, 0.14808720350265503, -0.07363148033618927, -7.805278816040143e-33, 0.011554635129868984, -0.04786685109138489, -0.014779089018702507, -0.032731469720602036, 0.08246804028749466, 0.021664775907993317, 0.1728927195072174, -0.006059134379029274, -0.04778935760259628, -0.0955541580915451, 0.1430089920759201, 0.06570866703987122, -0.03474435582756996, -0.03502149134874344, -0.008124271407723427, 0.05178544670343399, 0.014930710196495056, -0.07181498408317566, -0.10731091350317001, -0.008918536826968193, -0.020143860951066017, 0.18298287689685822, -0.05220464617013931, 0.0020231958478689194, 0.02848082408308983, 0.0037651648744940758, 0.11143478751182556, 0.09519615769386292, -0.025845082476735115, -0.025595074519515038, -0.09212775528430939, 0.06281007826328278, -0.2579367756843567, 0.054666273295879364, 0.08550512790679932, -0.06449219584465027, -0.019039615988731384, -0.19204081594944, 0.04730812832713127, -0.048474546521902084, 0.13420838117599487, 0.03514096513390541, -0.1176813393831253, 0.001412821002304554, 0.06994412839412689, 0.08393371105194092, 0.03614998608827591, -0.004354039207100868, 0.07242382317781448, -0.00848640501499176, -0.07009422779083252, -0.05929211527109146, -0.05214681476354599, -0.05814017355442047, -0.08906172960996628, 0.04637154936790466, 0.02208038419485092, -0.012830518186092377, -0.06654031574726105, -0.017442233860492706, 0.022745098918676376, 0.055323388427495956, 0.0800083726644516, -0.02138577587902546, -0.060850754380226135, 0.01415693387389183, 0.14890427887439728, -0.11313794553279877, -0.061786770820617676, -0.04137928783893585, -0.10724674165248871, -0.1267925500869751, -0.048267897218465805, 0.002024400047957897, -0.015447713434696198, -0.004806250333786011, -0.1801776885986328, -0.13735149800777435, -0.014139524661004543, -0.008767744526267052, -0.11509758234024048, -0.05558539927005768, -0.010710293427109718, 0.0833832323551178, 0.0838007926940918, 0.11642726510763168, -0.04028528928756714, -0.07396745681762695, 0.003826732747256756, 0.09612898528575897, -0.10967037826776505, -0.12542521953582764, -0.011968908831477165, 0.07542368024587631, -0.008312457241117954, -1.0123527260930132e-07, 0.09321502596139908, -0.0015651206485927105, 0.07377573847770691, -0.13738614320755005, 0.185646191239357, -0.12354354560375214, -0.15130677819252014, -0.047838445752859116, 0.18041154742240906, 0.09501088410615921, -0.01653517596423626, 0.03669298067688942, -0.02173234522342682, 0.04028521478176117, 0.020611880347132683, 0.06506389379501343, -0.025325603783130646, 0.08358092606067657, -0.023619677871465683, -0.11466662585735321, -0.05176282674074173, -0.017554262652993202, -0.01610015332698822, 0.05920163542032242, 0.04547267407178879, -0.03808792680501938, -0.002186378464102745, 0.10364258289337158, 0.03863278031349182, -0.05569962039589882, 0.10642041265964508, -0.007695375010371208, 0.11020874977111816, 0.09350989758968353, -0.038292914628982544, -0.15353792905807495, 0.10242737829685211, 0.012642532587051392, 0.008701784536242485, 0.20178437232971191, -0.012217923067510128, 0.003473433665931225, 0.045083705335855484, 0.05477289855480194, -0.08652404695749283, -0.05143509432673454, -0.0444682240486145, -0.005001810844987631, -0.03318995237350464, -0.03318168967962265, -0.07975649833679199, -0.09733504056930542, 0.02002749592065811, 0.027156727388501167, 0.01899728924036026, 0.07096820324659348, 0.010278345085680485, -0.10483802109956741, -0.04788663983345032, 0.14781929552555084, 0.04570208489894867, -0.14793670177459717, 0.14370191097259521, 0.023141391575336456], "changes": {"1wk": -8.804201555814425}}, {"text": "Cognition Therapeutics announces results in Phase 2 study of CT1812 TipRanks Thu, Dec 19, 2024, 3:31 PM 1 min read In This Article: CGTX https://www.tipranks.com/news/the-fly/okyo-pharma-receives-1-4m-in-non-dilutive-financing Cognition Therapeutics ( CGTX ) announced topline results from the exploratory Phase 2 \u2018SHIMMER\u2019 study demonstrating CT1812 produced strong therapeutic responses across behavioral, functional, cognitive, and movement measures in patients with dementia with Lewy bodies. Designed as a signal-finding study, the SHIMMER Phase 2 study enrolled 130 patients with mild-to-moderate DLB who were randomized to receive one of two oral doses of CT1812 or placebo daily for six months. Results indicate the study met its primary endpoint of safety and tolerability, with data showing that DLB patients treated with CT1812 for six months experienced improvement in behavioral, functional, cognitive and movement measures compared to placebo. Importantly, there was an 82% slowing in the total neuropsychiatric inventory with particularly strong reduction in anxiety, hallucinations, and delusions in the CT1812 treated arms. In addition, there was a marked reduction in caregiver distress, which suggests a positive impact on the day-to-day lives of those receiving the drug. Participants treated with CT1812 experienced a slowing of decline across all three cognitive measures compared to placebo, including fluctuations in attention which declined by 91%. Detailed data will be presented at the International Lewy Body Dementia Conference in January 2025. \u201cThese topline results exceeded our expectations and support the broad potential of CT1812 across neurodegenerative disorders,\u201d stated Anthony Caggiano, CMO and head of R&D. \u201cAnalysis of CT1812\u2019s activity in DLB will continue as additional data become available. We look forward to reporting these findings at future medical meetings and reviewing them with the FDA in an end-of-Phase 2 meeting.\u201d Pick the best stocks and maximize your portfolio: Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Published first on TheFly \u2013 the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on CGTX: Cognition announces all participants completed final visit in SHIMMER study Cognition Therapeutics provided an update on Phase 2 \u2018SHINE\u2019 study analysis Cognition Therapeutics Reports Promising Q3 2024 Results Cognition Therapeutics reports Q3 EPS (25c), consensus (22c) Cognition Therapeutics sees cash runway into 2Q25 View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-12-19T15:31:18", "sentiment": {"score": 0.7999622523784637, "confidence": 0.8436874747276306, "probabilities": {"positive": 0.8436874747276306, "negative": 0.04372522234916687, "neutral": 0.11258731782436371}}, "embedding": [0.0330381840467453, -0.09377185255289078, -0.05047193914651871, -0.021715568378567696, -0.1379697322845459, 0.04870593175292015, -0.025403600186109543, 0.18134599924087524, 0.048760972917079926, 0.0009848233312368393, -0.06550102680921555, 0.1919899582862854, -0.01035529375076294, -0.0016113203018903732, -0.035908713936805725, 0.08124703913927078, 0.0702924132347107, 0.05054864287376404, -0.1838037073612213, 0.127909854054451, -0.04188665747642517, 0.021293509751558304, 0.10331916809082031, 0.014954539015889168, -0.14076632261276245, 0.0814371407032013, -0.14117924869060516, -0.18419988453388214, -0.04481491819024086, -0.018056364730000496, 0.1590835452079773, 0.17934635281562805, -0.14668329060077667, -0.03561565279960632, -0.016775524243712425, -0.051735613495111465, -0.16237568855285645, 0.09798118472099304, 0.010660815984010696, -0.14524580538272858, 0.05269200727343559, 0.03781259059906006, -0.024239951744675636, 0.0625763088464737, -0.011100422590970993, -0.15054196119308472, -0.08418489992618561, -0.0570920966565609, -0.045482173562049866, -0.0812368243932724, -0.1183277890086174, -0.07916280627250671, 0.07848341017961502, 0.13859069347381592, -0.0673593282699585, 0.10528848320245743, -0.03831421583890915, 0.006123400293290615, -0.0010440703481435776, 0.08614762127399445, -0.09247767925262451, 0.024776915088295937, 0.09817329049110413, -0.052196845412254333, 0.11039739847183228, 0.08339764177799225, 0.026628125458955765, -0.05117486044764519, 0.0008042696863412857, -0.06199513375759125, 0.050950031727552414, -0.09388367831707001, 0.0165692251175642, -0.0011779144406318665, 0.06107278913259506, 0.03787191957235336, 0.03625130653381348, -0.026347532868385315, 0.1280408799648285, -0.163979634642601, -0.018174827098846436, 0.16981837153434753, 0.08091800659894943, 0.018194004893302917, 0.11512669175863266, -0.1216743066906929, 0.043529778718948364, 0.2103310227394104, -0.007802227512001991, 0.06496727466583252, 0.14311686158180237, -0.09924682229757309, -0.12674492597579956, -0.05998656153678894, 0.047197550535202026, -0.0781930685043335, -0.1029641181230545, 0.016103558242321014, -0.025284992530941963, -0.026005716994404793, 0.07860222458839417, 0.09524770081043243, -0.06144699081778526, -0.0427832305431366, -0.10991276800632477, -0.010472162626683712, 0.1843341886997223, -0.09779353439807892, 0.009054535999894142, -0.0036417804658412933, -0.12388205528259277, 0.07050642371177673, -0.01607145555317402, 0.019160272553563118, -0.09074799716472626, 0.022800590842962265, -0.10327162593603134, 0.06971226632595062, 0.24910232424736023, -0.047747522592544556, 0.13482707738876343, 0.00667805690318346, 0.09992298483848572, -0.015091365203261375, -0.012512939050793648, 0.019472133368253708, -0.16451731324195862, 1.2604523234072052e-32, -0.06248236820101738, -0.024645810946822166, -0.05502965301275253, 0.044959794729948044, 0.024689916521310806, -0.07099594920873642, -0.006885278970003128, -0.05959281325340271, 0.03949809819459915, -0.021482445299625397, -0.06918635964393616, 0.018477512523531914, 0.004745844751596451, 0.09413983672857285, -0.11910155415534973, -0.08463052660226822, -0.0924949049949646, 0.009699860587716103, -0.04102075472474098, 0.01449876744300127, 0.02127443626523018, 0.04002466797828674, -0.039415135979652405, 0.010462116450071335, -0.02822098322212696, 0.01882241852581501, -0.12417437881231308, 0.11182764172554016, -0.03152814134955406, 0.08812153339385986, -0.15762431919574738, -0.0222744420170784, -0.09417717158794403, -0.024366257712244987, -0.12204019725322723, -0.015253264456987381, 0.009630052372813225, -0.014653189107775688, 0.03697880357503891, -0.035724688321352005, 0.11899569630622864, 0.10472754389047623, -0.13195523619651794, 0.0005460991524159908, -0.03200993686914444, -0.048794105648994446, 0.07159856706857681, -0.0742114707827568, -0.07346505671739578, 0.012564337812364101, -0.06315460801124573, -0.10351267457008362, -0.011229355819523335, -0.05621837079524994, -0.10453540086746216, 0.11036944389343262, -0.0309089794754982, -0.09733045101165771, 0.12306520342826843, 0.01947140507400036, 0.16655972599983215, 0.15883097052574158, -0.1306574046611786, -0.05801764503121376, 0.018647756427526474, 0.024398725479841232, 0.007574652787297964, -0.03515550121665001, -0.1148698478937149, -0.021529916673898697, 0.02092365361750126, -0.06147751212120056, 0.16604356467723846, 0.09301330149173737, 0.09695684909820557, -0.09986396133899689, 0.09368910640478134, -0.022281231358647346, -0.08974030613899231, -0.10452189296483994, 0.1618122011423111, -0.11561498045921326, -0.07020693272352219, 0.05807188153266907, 0.024473771452903748, -0.014118649996817112, 0.05351419746875763, -0.06066389009356499, -0.2654515504837036, 0.03411959484219551, 0.0937059223651886, 0.018027732148766518, 0.07579070329666138, 0.08945418894290924, -0.04522870481014252, -1.3067096424167946e-32, -0.12195679545402527, 0.028924955055117607, 0.004731545224785805, -0.06853362917900085, 0.006730291992425919, 0.025403236970305443, 0.019260507076978683, -0.07224541902542114, 0.11278234422206879, -0.1884177327156067, 0.0590272918343544, -0.022868184372782707, -0.02272908017039299, 0.0368700847029686, -0.02387656643986702, 0.0011985939927399158, -0.04569755494594574, 0.02335597202181816, -0.05091863498091698, -0.04226839542388916, 0.036161310970783234, 0.14458562433719635, -0.17872217297554016, 0.11110524088144302, 0.0051089390181005, 0.13230013847351074, 0.10852625221014023, 0.11726593971252441, 0.04109470173716545, -0.008385028690099716, -0.062188517302274704, 0.10939336568117142, -0.09810049831867218, 0.054776500910520554, -0.08554896712303162, -0.0060688466764986515, 0.07997561991214752, -0.18041840195655823, -0.2070641815662384, -0.06463351845741272, 0.10737340152263641, 0.14554068446159363, 0.061858080327510834, 0.0517209991812706, 0.014040847308933735, -0.005477968603372574, 0.011895747855305672, -0.08262187242507935, 0.0035088378936052322, 0.1497933268547058, -0.005015872418880463, 0.09456834197044373, -0.03957369923591614, -0.004577300511300564, -0.07516127824783325, -0.059742271900177, 0.02137601003050804, -0.12029029428958893, -0.11425093561410904, -0.11257024854421616, 0.0066795432940125465, 0.13231287896633148, -0.1322135031223297, -0.03523886203765869, 0.14410868287086487, 0.061030156910419464, -0.01691555418074131, 0.06810035556554794, 0.012679348699748516, 0.012609523721039295, -0.08928569406270981, 0.004179005045443773, -0.03375363349914551, -0.16223952174186707, 0.003950207494199276, 0.11435789614915848, -0.03333636373281479, -0.08897113800048828, 0.06953905522823334, -0.14347057044506073, -0.0562325194478035, 0.006601232104003429, 0.0028095277957618237, 0.021755509078502655, -0.06678279489278793, 0.0646778792142868, -0.08744195103645325, -0.009771952405571938, -0.0717061311006546, -0.03659481555223465, -0.02558385208249092, -0.13843965530395508, -0.09828314185142517, 0.07715238630771637, -0.050031520426273346, -1.006257690505663e-07, -0.00975094735622406, -0.08811849355697632, -0.018786828964948654, -0.02200368419289589, 0.08449560403823853, -0.03262713924050331, -0.02033720724284649, 0.0741526335477829, -0.06741324812173843, 0.15325301885604858, 0.09082520753145218, 0.09257657825946808, -0.07835166156291962, -0.04556451737880707, -0.052616994827985764, 0.09729289263486862, -0.07196418941020966, 0.05230962112545967, -0.07037602365016937, -0.0957227498292923, 0.05643201246857643, 0.04245183616876602, 0.11568669974803925, -0.10722838342189789, 0.027883434668183327, -0.043336451053619385, 0.07871647924184799, 0.13649314641952515, -0.032782796770334244, -0.12828978896141052, -0.012923002243041992, 0.059762727469205856, -0.033022619783878326, -0.028086107224225998, 0.05657557025551796, -0.058574479073286057, 0.17081639170646667, -0.012652261182665825, 0.06253758817911148, 0.13146385550498962, 0.047366004437208176, -0.010904671624302864, -0.0021163607016205788, 0.060955971479415894, 0.0736110657453537, -0.08016101270914078, -0.032374463975429535, -0.03904927894473076, 0.09720546007156372, -0.1387566477060318, 0.07777899503707886, 0.17529422044754028, 0.03061196208000183, 0.09227706491947174, -0.09186701476573944, 0.18021783232688904, -0.0732346773147583, 0.01049039140343666, -0.05304539576172829, -0.08266623318195343, 0.12415888905525208, 0.0712265893816948, -0.00235024094581604, 0.018740013241767883], "changes": {"1wk": 2.208201655486095, "1mo": 7.570974418419904}}, {"text": "PREMIUM Cognition Therapeutics Says Study of Drug to Treat Lewy Body Dementia Meets Primary Endpoint; Shares Jump MT Newswires Wed, Dec 18, 2024, 4:49 PM 1 min read In This Article: CGTX Cognition Therapeutics (CGTX) said Wednesday that a phase 2 study of CT1812 to treat patients with L PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-12-18T16:49:21", "sentiment": {"score": 0.0665098624303937, "confidence": 0.07823878526687622, "probabilities": {"positive": 0.07823878526687622, "negative": 0.011728922836482525, "neutral": 0.910032331943512}}, "embedding": [-0.035059504210948944, 0.008001166395843029, -0.023062802851200104, -0.061645377427339554, -0.05964098498225212, 0.1180783361196518, -0.10563588887453079, 0.1318557858467102, -0.06778492033481598, -0.0598759800195694, -0.0006459693540818989, 0.2032221257686615, -0.036788057535886765, 0.10513168573379517, 0.0860680639743805, 0.06600293517112732, 0.022507427260279655, 0.04118325933814049, 0.009756023995578289, 0.048812512308359146, -0.040455691516399384, 0.09213472902774811, 0.08976376056671143, 0.00806976854801178, -0.1094108298420906, -0.0043097008019685745, -0.14795048534870148, -0.2528618276119232, 0.10190768539905548, 0.05877054110169411, 0.16066835820674896, 0.13212443888187408, -0.17537745833396912, -0.059936150908470154, 0.007929813116788864, -0.08980973809957504, -0.1929728388786316, 0.08149080723524094, -0.09998419880867004, -0.09640169888734818, 0.02809799276292324, -0.03161121532320976, -0.06464065611362457, 0.06556358188390732, 0.031756557524204254, -0.05711790546774864, -0.07480286061763763, -0.065030537545681, -0.019632142037153244, -0.14111171662807465, 0.010011550039052963, -0.1040395125746727, 0.06770557910203934, 0.06431744992733002, -0.09099134802818298, 0.15523450076580048, -0.1626938283443451, -0.00691096531227231, -0.02390475384891033, -0.018453901633620262, -0.11505265533924103, -0.04619068652391434, 0.016391484066843987, -0.013872990384697914, -0.03340035304427147, 0.06104298681020737, 0.018488449975848198, 0.05586457997560501, 0.05962861329317093, -0.16326956450939178, -0.09866583347320557, 0.0009854285744950175, 0.05543744936585426, 0.02414022572338581, 0.20653089880943298, 0.07712923735380173, 0.019728288054466248, -0.1027466431260109, 0.10277015715837479, -0.24295154213905334, -0.06358295679092407, 0.11604910343885422, 0.0495818555355072, 0.03821362182497978, 0.19216637313365936, -0.08017157018184662, -0.007973726838827133, 0.16946099698543549, -0.1335543394088745, -0.0786958560347557, 0.13221800327301025, -0.13181878626346588, -0.20313216745853424, -0.02734735980629921, -0.10108349472284317, -0.1123533695936203, -0.04192839190363884, -0.09653471410274506, -0.12655416131019592, -0.02641475759446621, 0.08156848698854446, 0.05057623237371445, 0.08059048652648926, -0.022250430658459663, -0.07950056344270706, -0.08408897370100021, 0.15664075314998627, 0.005564775317907333, -0.003923431970179081, -0.03277328982949257, 0.03780316933989525, -0.006042717024683952, 0.03432849794626236, -0.06514691561460495, -0.026232879608869553, 0.07906758785247803, -0.1515561044216156, 0.08279070258140564, 0.2528811991214752, -0.10582038015127182, 0.07067826390266418, -0.03800051286816597, -0.015269913710653782, -0.0080091068521142, 0.02440096065402031, 0.013171888887882233, -0.10016290843486786, 1.3785648202834778e-32, -0.1183919906616211, 0.033674247562885284, -0.08256798982620239, 0.0727158635854721, 0.05519717186689377, -0.05391673743724823, 0.008804275654256344, -0.09906738996505737, 0.08544518798589706, -0.0736851841211319, -0.03297724947333336, 0.069318026304245, -0.026638563722372055, 0.2200128138065338, -0.2348569929599762, -0.05157053470611572, -0.08435481041669846, 0.18343022465705872, -6.892099918331951e-05, 0.0345778614282608, 0.02975711040198803, 0.15053877234458923, 0.01673280820250511, -0.07366868108510971, -0.09845451265573502, 0.037351466715335846, -0.034275323152542114, 0.020315688103437424, 0.09960856288671494, 0.09456095844507217, -0.17743384838104248, 0.04297848790884018, -0.05523828789591789, 0.05048707127571106, -0.05782695487141609, 0.13850189745426178, 0.046070393174886703, -0.061368126422166824, 0.06576663255691528, -0.13113421201705933, 0.13164854049682617, 0.1304994821548462, -0.07909233123064041, -0.026095492765307426, -0.05555702745914459, -0.04293198883533478, 0.11427748948335648, -0.14409978687763214, -0.029415084049105644, -0.08455479145050049, -0.0004768817452713847, -0.03409203886985779, -0.22490054368972778, -0.041120368987321854, -0.008731779642403126, 0.09612081944942474, -0.10131113976240158, 0.009725820273160934, 0.23829209804534912, -0.05142456293106079, 0.2528022229671478, 0.12482691556215286, -0.11268509179353714, -0.08715775609016418, 0.036037739366292953, 0.024501964449882507, -0.028355885297060013, -0.14788563549518585, -0.08362951874732971, 0.014436452649533749, 0.06890536099672318, -0.10228871554136276, 0.042985301464796066, 0.08134721219539642, 0.08438877761363983, -0.055241744965314865, 0.20141810178756714, -0.015945786610245705, 0.09849461913108826, -0.06468982994556427, 0.16790856420993805, -0.08032114803791046, 0.009349463507533073, 0.06230192258954048, 0.053091298788785934, 0.01890181377530098, -0.052658792585134506, -0.06660910695791245, -0.22067873179912567, 0.0850318968296051, 0.05120686814188957, 0.02881602942943573, 0.013947276398539543, 0.1785293072462082, -0.05867133289575577, -1.7606070964564447e-32, -0.11780495196580887, 0.004341591149568558, 0.01673922874033451, -0.08793962001800537, 0.020794251933693886, 0.03940014913678169, -0.06379084289073944, -0.11979714035987854, 0.2603718638420105, -0.01137846615165472, 0.16414672136306763, -0.03995172679424286, -0.17200562357902527, 0.09285007417201996, 0.07138777524232864, -0.034233804792165756, -0.023137258365750313, -0.009957656264305115, -0.08378695696592331, 0.040774811059236526, -0.04448258504271507, 0.17893089354038239, -0.13751763105392456, 0.13512872159481049, 0.08534909039735794, 0.03002508543431759, 0.030760644003748894, 0.1296733021736145, 0.026530317962169647, -0.014189740642905235, -0.12316929548978806, -0.02693926729261875, -0.11124072223901749, -0.02998809702694416, -0.08239425718784332, -0.07524966448545456, 0.18939657509326935, -0.01903434842824936, -0.2569712698459625, -0.016894299536943436, 0.10646548867225647, -0.11400993168354034, 0.012609194964170456, 0.013542846776545048, 0.04468531534075737, -0.050213512033224106, -0.006383304018527269, -0.06518981605768204, 0.06596169620752335, 0.2206079661846161, 0.008280966430902481, -0.012741176411509514, 0.052762653678655624, -0.09824138879776001, -0.13560888171195984, -0.07493608444929123, 0.04327651113271713, -0.154343843460083, -0.02437438629567623, -0.14796969294548035, 0.030191348865628242, 0.1108119934797287, -0.2630111277103424, -0.006079368758946657, 0.12044302374124527, 0.11243464052677155, 0.02320832386612892, 0.04689517989754677, -0.023028865456581116, -0.005859910044819117, -0.08899307250976562, 0.08799287676811218, -0.1183018907904625, -0.2477334588766098, 0.013143117539584637, 0.0896780863404274, -0.04200900346040726, -0.11478622257709503, 0.03400231525301933, -0.16561239957809448, -0.036735061556100845, -0.10234244167804718, -0.017307808622717857, -0.011602617800235748, -0.05557367950677872, 0.008444097824394703, -0.05909893289208412, 0.021144185215234756, -0.07809089869260788, 0.016350965946912766, -0.07669160515069962, -0.06852901726961136, -0.16229504346847534, 0.017276953905820847, -0.03851703926920891, -1.011829056096758e-07, -0.012059921398758888, -0.05055281147360802, 0.03684493154287338, -0.0686807632446289, -0.046875808387994766, 0.017830463126301765, -0.12564460933208466, 0.127801313996315, -0.04786902666091919, 0.13140471279621124, 0.02652944065630436, 0.08597259223461151, 0.08185718953609467, -0.1111692413687706, -0.0917908325791359, 0.03980516269803047, -0.03108556568622589, 0.13144737482070923, -0.06720889359712601, -0.14029331505298615, 0.0035425666719675064, 0.04051345959305763, 0.17015424370765686, -0.14145885407924652, 0.016043584793806076, -0.0317087285220623, 0.10475905239582062, 0.13772499561309814, -0.04073362052440643, -0.21974992752075195, -0.025211602449417114, 0.07651150971651077, -0.08785703033208847, 0.04804656654596329, 0.12060429155826569, -0.09998561441898346, 0.1864677220582962, 0.023791270330548286, 0.03278898447751999, 0.06280838698148727, 0.08524226397275925, -0.007187035400420427, 0.03136417269706726, 0.06604801118373871, 0.06009172648191452, -0.07598415017127991, 0.05403657257556915, -0.12516172230243683, 0.059751179069280624, -0.07505080103874207, 0.08350682258605957, 0.16276605427265167, 0.10157284140586853, -0.005849573761224747, -0.07203906774520874, 0.12156040966510773, -0.018189724534749985, -0.08017387986183167, -0.10748589783906937, -0.042417459189891815, 0.15973342955112457, 0.06935510039329529, 0.09575426578521729, 0.06112032011151314], "changes": {"1wk": 11.724141474711445, "1mo": 19.655176843389306}}, {"text": "PREMIUM B. Riley Upgrades Cognition Therapeutics to Buy From Neutral, Lifts PT to $1.50 From $1 MT Newswires Thu, Dec 19, 2024, 4:15 PM In This Article: CGTX Cognition Therapeutics (CGTX) has an average rating of buy and mean price target of $7.75, according PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-12-19T16:15:07", "sentiment": {"score": 0.08235115464776754, "confidence": 0.09424284845590591, "probabilities": {"positive": 0.09424284845590591, "negative": 0.01189169380813837, "neutral": 0.8938654065132141}}, "embedding": [-0.0494329109787941, -0.10183385014533997, 0.02478506974875927, -0.009474007412791252, -0.08091671019792557, 0.08612676709890366, 0.1888158768415451, 0.30391567945480347, 0.08487796038389206, 0.11793169379234314, 0.002482003066688776, 0.07758911699056625, -0.03452134132385254, 0.058045946061611176, 0.025035010650753975, 0.008045991882681847, 0.21991890668869019, -0.0031376788392663, 0.07522931694984436, 0.05324072018265724, -0.1728876531124115, 0.0054737175814807415, 0.02088267356157303, 0.03262075036764145, 0.10488419979810715, -0.0022345108445733786, -0.13945291936397552, -0.2169109284877777, 0.1060427650809288, 0.06482286006212234, -0.07756170630455017, -0.05016934871673584, -0.04287820681929588, -0.08814425021409988, -0.01525302417576313, -0.17049293220043182, -0.11464512348175049, 0.063118577003479, -0.14482514560222626, -0.09840722382068634, 0.05175774171948433, 0.038824424147605896, -0.23065464198589325, 0.05776218697428703, -0.012816586531698704, -0.006360843777656555, -0.01867324486374855, 0.05019806697964668, 0.03155479580163956, 0.030262915417551994, -0.06954987347126007, -0.11069876700639725, 0.007849273271858692, -0.0461093932390213, -0.09067185968160629, 0.13088321685791016, -0.11323121190071106, -0.01692274771630764, -0.013914790004491806, -0.044498834758996964, -0.10677847266197205, -0.12168972939252853, 0.014942662790417671, 0.03273078799247742, 0.08917836099863052, 0.1276678740978241, -0.05235087499022484, 0.013143557123839855, 0.08661249279975891, -0.1949504166841507, -0.08846864104270935, 0.08576154708862305, 0.2111833542585373, -0.06452453881502151, 0.14773090183734894, 0.10874471068382263, 0.15848210453987122, -0.170103058218956, 0.0979430302977562, -0.12210521847009659, 0.023494035005569458, 0.04264824837446213, 0.015224415808916092, -0.02237487956881523, 0.25812554359436035, -0.025738663971424103, 0.16219334304332733, 0.18643470108509064, 0.026586761698126793, -0.03902173414826393, 0.12554048001766205, -0.06522931158542633, -0.15753288567066193, -0.08933866024017334, -0.10338497906923294, -0.014172696508467197, -0.1597106009721756, -0.05272936448454857, -0.04058689996600151, -0.020054494962096214, 0.1026206687092781, 0.10101985931396484, -0.0028131355065852404, -0.033511318266391754, -0.11885138601064682, -0.12206470966339111, -0.05089351907372475, 0.03553223982453346, 0.10897000133991241, -0.013529081828892231, -0.17023760080337524, 0.006448541767895222, -0.026767170056700706, -0.1410050243139267, -0.11098804324865341, 0.20284053683280945, -0.11290494352579117, 0.011350576765835285, 0.29421746730804443, -0.11318905651569366, -0.0015582145424559712, -0.1603625863790512, -0.07525038719177246, 0.1281684935092926, -0.1173984557390213, -0.0576208233833313, -0.06219042092561722, 9.625577368694549e-33, -0.21159596741199493, 0.16434770822525024, -0.04060591757297516, -0.06274817138910294, -0.04866708070039749, -0.010215195827186108, 0.10479859262704849, -0.05274374037981033, -0.13701727986335754, -0.021407892927527428, -0.16440431773662567, 0.18755745887756348, -0.008210720494389534, 0.27039816975593567, -0.10361292213201523, -0.18452276289463043, -0.0822482630610466, 0.1754225790500641, 0.06909891963005066, -0.0542866587638855, 0.02236928418278694, 0.054712891578674316, -0.0032024600077420473, 0.008646787144243717, -0.13486680388450623, 0.09026637673377991, -0.07246306538581848, 0.18864449858665466, 0.12679296731948853, -0.003989806864410639, -0.22665980458259583, 0.0632033571600914, 0.09416715800762177, 0.032596785575151443, -0.06391919404268265, 0.028637710958719254, 0.02918565645813942, -0.1280660182237625, 0.08330942690372467, -0.10607996582984924, -0.013882570900022984, 0.22364698350429535, 0.014902223832905293, -0.08346571773290634, 0.03249628096818924, -0.06206802278757095, -0.039138395339250565, -0.19306297600269318, -0.10735921561717987, -0.14551256597042084, -0.13324196636676788, 0.14246629178524017, -0.16342006623744965, -0.016089731827378273, -0.13322196900844574, -0.021909935399889946, -0.02400558441877365, 0.014437761157751083, 0.23385575413703918, 0.03158321976661682, 0.11141589283943176, 0.10401846468448639, -0.03601037338376045, -0.09795848280191422, -0.023686982691287994, 0.24460503458976746, -0.15443465113639832, -0.07158836722373962, -0.10155337303876877, 0.12634791433811188, 0.016150273382663727, 0.07960135489702225, 0.049319423735141754, -0.12411199510097504, 0.1359529197216034, 0.039975035935640335, -0.0033776394557207823, -0.08602938055992126, 0.10163427889347076, -0.09399764984846115, 0.004296652507036924, -0.07372414320707321, -0.025376075878739357, 0.15432101488113403, 0.21194809675216675, -0.020465215668082237, -0.2034798413515091, 0.00035054696490988135, -0.14531660079956055, 0.05286552011966705, 0.15825743973255157, 0.020007571205496788, -0.17635883390903473, 0.12969690561294556, -0.10294294357299805, -1.0781991242151083e-32, -0.06925296038389206, 0.08613158762454987, -0.05405210703611374, 0.0366046167910099, -0.03301196172833443, 0.04084061458706856, -0.0891653299331665, -0.01112329587340355, 0.20900604128837585, 0.12391979247331619, 0.07786961644887924, 0.08529941737651825, -0.13798323273658752, 0.18194246292114258, 0.004011297598481178, -0.033908989280462265, -0.0178616214543581, 0.07318289577960968, -0.03467809036374092, -0.06004553660750389, 0.003942710347473621, 0.25764209032058716, -0.07423822581768036, 0.15894682705402374, 0.0006510384264402092, 0.09528844803571701, 0.03431849181652069, 0.1600188910961151, 0.046160172671079636, 0.016487058252096176, -0.1506117880344391, 0.01711401157081127, -0.13414858281612396, 0.12256833910942078, -0.08160453289747238, 0.05537281930446625, 0.15737713873386383, 0.06941640377044678, -0.05896264314651489, 0.05158786475658417, -0.016773955896496773, -0.052998680621385574, 0.04658076912164688, -0.07697398215532303, 0.14359603822231293, -0.07809209823608398, -0.0013001183979213238, -0.06368889659643173, 0.07568548619747162, 0.23729726672172546, -0.023182498291134834, -0.06612338125705719, 0.10650840401649475, -0.10698508471250534, -0.24655260145664215, -0.0001804984494810924, 0.06979842483997345, -0.08564680069684982, 0.017474118620157242, -0.08056844770908356, 0.07113920152187347, 0.2045888900756836, -0.13864704966545105, -0.024564506486058235, 0.04391803592443466, 0.15464088320732117, 0.08263885229825974, 0.04375061020255089, -0.011740235611796379, -0.04513977840542793, -0.07594217360019684, 0.1456882208585739, -0.03745206072926521, -0.321101576089859, 0.03237015753984451, 0.16262036561965942, 0.024411004036664963, -0.020662570372223854, 0.07545064389705658, -0.10465855151414871, -0.019911879673600197, -0.10123149305582047, 0.18211039900779724, -0.052239615470170975, -0.02582944743335247, -0.021242255344986916, -0.08873481303453445, 0.057131871581077576, -0.052904289215803146, 0.08911051601171494, -0.14271990954875946, -0.011942257173359394, -0.014248489402234554, -0.07093370705842972, 0.06283921003341675, -1.0046468190694213e-07, -0.055108822882175446, 0.06105544790625572, 0.0001450508862035349, 0.08174170553684235, 0.06820043921470642, 0.02020115591585636, -0.0936795100569725, 0.027843128889799118, -0.08395786583423615, 0.09374332427978516, -0.045086074620485306, -0.07939699292182922, -0.009855079464614391, -0.040381595492362976, -0.18934372067451477, -0.030669676139950752, -0.07373975217342377, 0.07217219471931458, 0.0038100839592516422, -0.0823865607380867, -0.058163974434137344, 0.0849432498216629, 0.16376693546772003, -0.0001764821499818936, -0.014422623440623283, -0.031694259494543076, 0.005303795449435711, 0.09459532797336578, 0.02410581149160862, -0.017851166427135468, -0.028528694063425064, 0.03749392554163933, 0.01266926247626543, 0.14310486614704132, 0.11793693155050278, -0.14303098618984222, -0.11072209477424622, 0.16712737083435059, -0.07452535629272461, 0.03292069211602211, 0.04763029143214226, -0.16799837350845337, -0.07480134069919586, 0.03569581359624863, 0.02337707206606865, 0.04764838516712189, -0.1632942110300064, -0.22812911868095398, 0.06490053236484528, -0.026010653004050255, 0.20237119495868683, 0.13026846945285797, -0.13896594941616058, -0.036919765174388885, -0.06250960379838943, -0.04143700376152992, -0.043852824717760086, 0.009276572614908218, -0.17900250852108002, 0.020720211789011955, 0.0316113643348217, -0.20965953171253204, 0.006694096140563488, -0.010571632534265518], "changes": {"1wk": 2.208201655486095, "1mo": 7.570974418419904}}, {"text": "B. Riley upgrades Cognition Therapeutics to Buy on Lewy bodies data TipRanks Fri, Dec 20, 2024, 3:21 PM 1 min read In This Article: CGTX https://www.tipranks.com/news/the-fly/ovid-therapeutics-upgraded-at-oppenheimer-as-ov329s-promise-quite-real B. Riley analyst Mayank Mamtani upgraded Cognition Therapeutics ( CGTX ) to Buy from Neutral with a price target of $1.50, up from $1. The company\u2019s topline results from the Phase 2 SHIMMER study of CT1812 in patients with dementia with Lewy bodies exceeded expectations in terms of consistency and magnitude of treatment effect, the analyst tells investors in a research note. The firm says Cognition is \u201chere to stay, even thrive now\u201d on the back of these results. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Published first on TheFly \u2013 the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today\u2019s best-performing stocks on TipRanks >> Read More on CGTX: Cognition Therapeutics upgraded to Buy from Neutral at B. Riley Cognition Therapeutics price target raised to $6 from $5 at H.C. Wainwright Cognition Therapeutics announces results in Phase 2 study of CT1812 Cognition announces all participants completed final visit in SHIMMER study Cognition Therapeutics provided an update on Phase 2 \u2018SHINE\u2019 study analysis View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-12-20T15:21:36", "sentiment": {"score": 0.8204214246943593, "confidence": 0.8332818150520325, "probabilities": {"positive": 0.8332818150520325, "negative": 0.012860390357673168, "neutral": 0.1538577675819397}}, "embedding": [-0.046199288219213486, -0.13313010334968567, -0.08385898172855377, 0.059057436883449554, -0.05785507708787918, 0.03108927048742771, 0.07453618943691254, 0.19057847559452057, 0.0028559945058077574, 0.05387154221534729, 0.0005316532333381474, 0.1865079253911972, -0.03547539561986923, 0.08423116058111191, -0.02369181625545025, 0.10301942378282547, 0.12914183735847473, 0.029174339026212692, -0.08509889990091324, 0.07028844952583313, -0.11369838565587997, -0.034293003380298615, 0.11548947542905807, -0.0032373175490647554, -0.03919937089085579, 0.03138675168156624, -0.15584908425807953, -0.14862175285816193, -0.06992883235216141, -0.0944567397236824, 0.022034313529729843, 0.12317346781492233, -0.07332520186901093, -0.049507323652505875, -0.12512773275375366, -0.05454419180750847, -0.12516096234321594, 0.08860152959823608, -0.017446467652916908, -0.09545913338661194, 0.07740437984466553, -0.021070891991257668, -0.12251731008291245, 0.02718283422291279, 0.04627504572272301, -0.08622308075428009, -0.04444897919893265, -0.07315272837877274, -0.003546080319210887, -0.0619821771979332, -0.23636868596076965, -0.09628624469041824, 0.040156252682209015, 0.07725021988153458, -0.09048959612846375, 0.12975160777568817, -0.11487074196338654, -0.03551463782787323, -0.05632208660244942, -0.03925507515668869, -0.03976459428668022, -0.046285584568977356, 0.15327216684818268, -0.06547380238771439, 0.15903949737548828, 0.011802414432168007, -0.02905769646167755, 0.009801218286156654, -0.03659377619624138, -0.05834248661994934, 0.07709520310163498, -0.048294827342033386, -0.006610135082155466, -0.017070474103093147, 0.10560892522335052, 0.08702569454908371, 0.03144821524620056, -0.05977421626448631, 0.17727530002593994, -0.09159495681524277, -0.035621482878923416, 0.03143714740872383, 0.018360568210482597, -0.029316037893295288, 0.08816725760698318, -0.10587815195322037, 0.05107707157731056, 0.16805614531040192, -0.022749098017811775, 0.053703274577856064, 0.1533513367176056, -0.11499670147895813, -0.069915272295475, -0.04295673966407776, 0.05709715932607651, -0.02048451453447342, -0.10301846265792847, -0.03154558315873146, 0.004516065586358309, -0.017948929220438004, 0.08466877043247223, 0.06731604784727097, -0.03105105459690094, -0.09314234554767609, -0.017786869779229164, -0.10618765652179718, 0.14132463932037354, -0.02854248136281967, 0.09630999714136124, -0.010480476543307304, -0.082196444272995, 0.08199378103017807, -0.01307637244462967, 0.02444133162498474, -0.139384463429451, 0.16210325062274933, -0.146341934800148, 0.11805947124958038, 0.2662700414657593, -0.008371865376830101, 0.15577253699302673, 0.010746120475232601, 0.08720004558563232, 0.022865112870931625, -0.01129674632102251, 0.06787785142660141, -0.15882928669452667, 1.1544787158814928e-32, -0.11047892272472382, 0.04582197591662407, -0.03291074186563492, 0.0382150337100029, -0.05552509427070618, -0.08141463994979858, 0.032579272985458374, -0.06173289194703102, -0.03932737186551094, -0.03090677410364151, -0.12273470312356949, 0.08100014179944992, 0.03585321083664894, 0.1644698679447174, -0.1312771588563919, -0.088612861931324, -0.058506764471530914, 0.04505361244082451, -0.048759825527668, -0.06495990604162216, 0.09928824007511139, 0.07876551151275635, -0.023958636447787285, -0.08560919016599655, -0.0584426112473011, -0.07906519621610641, -0.1464831531047821, 0.03842715919017792, 0.009144091978669167, 0.08083705604076385, -0.08411688357591629, 0.05580274760723114, -0.086179219186306, -0.034651048481464386, -0.052529435604810715, 0.002616973826661706, -0.02891731821000576, -0.11722345650196075, 0.06439578533172607, -0.06256359815597534, 0.06692530959844589, 0.15870045125484467, -0.05204729363322258, -0.04865286871790886, -0.0376724936068058, -0.0035522873513400555, -0.01972024142742157, -0.078994981944561, -0.04431391507387161, -0.08196640014648438, -0.06658165901899338, -0.03095187246799469, 0.003965322393923998, -0.08049936592578888, -0.06326800584793091, 0.12376124411821365, -0.07664139568805695, -0.022893043234944344, 0.06218830868601799, 0.019086312502622604, 0.14966218173503876, 0.14683406054973602, -0.10237092524766922, -0.11109530180692673, -0.10403966158628464, 0.10620401799678802, 0.014885740354657173, 0.0507311150431633, -0.14946848154067993, 0.10930601507425308, 0.09831148386001587, -0.0275039691478014, 0.07913785427808762, -0.00850636139512062, 0.06932195276021957, -0.08177969604730606, 0.09340579062700272, 0.006350757088512182, -0.012195449322462082, -0.1404673457145691, 0.19081421196460724, -0.000565238413400948, -0.08235885947942734, 0.0845278948545456, 0.04334409162402153, 0.0252851489931345, -0.04706098884344101, -0.04766512289643288, -0.1791699379682541, 0.027113085612654686, 0.05872155353426933, 0.044461529701948166, 0.029350263997912407, 0.06504519283771515, -0.11311641335487366, -1.2422425934818233e-32, -0.1446968913078308, -0.00789625383913517, -0.00924074836075306, 0.0051725502125918865, 0.029487114399671555, 0.016545070335268974, 0.0054955678060650826, -0.13742674887180328, 0.10624411702156067, -0.051504772156476974, 0.0893753170967102, 0.020007001236081123, -0.09669040143489838, 0.0029679408762604, -0.030353480949997902, -0.008070658892393112, -0.11089757084846497, -0.05482947453856468, -0.015383976511657238, -0.0415499210357666, 0.030165962874889374, 0.18782936036586761, -0.11016983538866043, 0.15437300503253937, 0.015818923711776733, 0.13728117942810059, 0.044042475521564484, 0.11492430418729782, 0.038465648889541626, -0.0016028760001063347, -0.11139614135026932, 0.007140790577977896, -0.12959137558937073, 0.05668778717517853, -0.042365528643131256, 0.0297843124717474, 0.13542978465557098, -0.19122286140918732, -0.17157384753227234, 0.026231568306684494, 0.04905932396650314, 0.017526686191558838, 0.04227975755929947, -0.014789306558668613, 0.08120246976613998, 0.04117092117667198, -0.016140080988407135, 0.02582596056163311, 0.08019258826971054, 0.16506032645702362, 0.015424659475684166, 0.04469643160700798, -0.0051786210387945175, 0.0015160893090069294, -0.16450299322605133, -0.04596813768148422, 0.02470610849559307, -0.07619750499725342, -0.1245233342051506, -0.07295139878988266, -0.0334952138364315, 0.11299309134483337, -0.06055606156587601, 0.017484448850154877, -0.010976271703839302, 0.1153297945857048, -0.021526703611016273, 0.09320968389511108, -0.049814727157354355, -0.08568079769611359, -0.09318286180496216, -0.014395834878087044, -0.021055784076452255, -0.1908242106437683, 0.033951859921216965, 0.1722353845834732, -0.024121617898344994, -0.0982651486992836, -0.0034400413278490305, -0.08253226429224014, -0.0289023295044899, -0.018567336723208427, 0.03690894693136215, 0.042397286742925644, 0.027199111878871918, 0.06504745781421661, -0.06012755632400513, 0.009310613386332989, -0.04768994450569153, -0.08475306630134583, -0.062103159725666046, -0.1529722958803177, -0.08096207678318024, 0.021713614463806152, -0.04756651073694229, -1.0084718837788387e-07, 0.003875799709931016, -0.08509211242198944, 0.07483449578285217, 0.01048961840569973, 0.0566825345158577, -0.039654601365327835, -0.07893621921539307, 0.09000888466835022, -0.025424612686038017, 0.10548683255910873, -0.014201142825186253, 0.05575745925307274, -0.0996377170085907, -0.08605055510997772, -0.029969606548547745, -0.005507782567292452, -0.09245859831571579, 0.07671689987182617, -0.03101532906293869, -0.13048943877220154, 0.06489875167608261, 0.04120849445462227, 0.14242534339427948, -0.033183228224515915, 0.017606869339942932, -0.007879107259213924, 0.014813369140028954, 0.022600427269935608, -0.04832712933421135, -0.05133749172091484, 0.025475092232227325, 0.022376256063580513, 0.10703963041305542, 0.03755788877606392, 0.16925764083862305, -0.11219410598278046, 0.13181523978710175, 0.03389578312635422, 0.00633613858371973, 0.12773944437503815, 0.02595832571387291, -0.04059286043047905, 0.033551640808582306, 0.050107717514038086, 0.08191666007041931, -0.08840501308441162, -0.031257372349500656, -0.023748818784952164, 0.11174315214157104, -0.06172594055533409, 0.18293684720993042, 0.06278054416179657, -0.033737942576408386, 0.06386484205722809, -0.0678575411438942, 0.07057081162929535, -0.029045309871435165, -0.005836011841893196, -0.15023915469646454, -0.025405997410416603, 0.17532101273536682, -0.06118042767047882, 0.014762261882424355, 0.1041102409362793], "changes": {"1wk": 21.746035770734423, "1mo": 8.253966121476537}}, {"text": "Cognition Therapeutics (CGTX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Zacks Equity Research Thu, Nov 28, 2024, 5:55 PM 3 min read In This Article: CGTX The price trend for Cognition Therapeutics, Inc. (CGTX) has been bearish lately and the stock has lost 9.6% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support. While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earnings of this company is a solid fundamental factor that enhances the prospects of a trend reversal for the stock. Understanding Hammer Chart and the Technique to Trade It This is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.' In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price. When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal. Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors. Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators. Here's What Makes the Trend Reversal More Likely for CGTX There has been an upward trend in earnings estimate revisions for CGTX lately, which can certainly be considered a bullish indicator on the fundamental side. That's because a positive trend in earnings estimate revisions usually translates into price appreciation in the near term. The consensus EPS estimate for the current year has increased 14.1% over the last 30 days. This means that the Wall Street analysts covering CGTX are majorly in agreement about the company's potential to report better earnings than what they predicted earlier. Story Continues If this is not enough, you should note that CGTX currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Moreover, a Zacks Rank of 2 for Cognition Therapeutics is a more conclusive indication of a potential trend reversal, as the Zacks Rank has proven to be an excellent timing indicator that helps investors identify precisely when a company's prospects are beginning to improve. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cognition Therapeutics, Inc. (CGTX) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-11-28T17:55:07", "sentiment": {"score": -0.40573760867118835, "confidence": 0.4659929573535919, "probabilities": {"positive": 0.060255348682403564, "negative": 0.4659929573535919, "neutral": 0.47375160455703735}}, "embedding": [-0.09219444543123245, -0.019932787865400314, 0.12865200638771057, 0.05960134044289589, -0.05787397176027298, 0.02030426450073719, -0.014351077377796173, 0.16440163552761078, 0.18790492415428162, 0.08213229477405548, -0.10550110042095184, 0.16594454646110535, -0.037920694798231125, -0.058226488530635834, -0.01210670918226242, 0.00020087140728719532, -0.04530090093612671, -0.10182802379131317, -0.13356752693653107, 0.043640073388814926, 0.01036880910396576, -0.12684759497642517, -0.05390464514493942, 0.0014384789392352104, -0.08006969094276428, 0.035344094038009644, -0.11951448023319244, 0.005637929774820805, 0.10085821896791458, -0.00025783805176615715, -0.017248917371034622, 0.13410955667495728, -0.013847220689058304, 0.03142357990145683, -0.1779996156692505, -0.036191314458847046, -0.0011285347864031792, 0.12349499017000198, 0.09318525344133377, 0.008507629856467247, 0.01814599148929119, 0.026901613920927048, -0.12096118181943893, 0.023102154955267906, 0.005889357067644596, 0.011267191730439663, -0.013110978528857231, -0.02724546566605568, -0.1011652871966362, 0.0038927444256842136, -0.08413670212030411, -0.044012583792209625, 0.022864816710352898, 0.08732809126377106, -0.012197690084576607, 0.07607915997505188, -0.010340615175664425, -0.03624776005744934, 0.176015704870224, 0.020830504596233368, 0.05588386207818985, 0.09098579734563828, -0.09581916034221649, 0.034076303243637085, 0.22489872574806213, 0.005889182910323143, 0.01573239639401436, 0.009806034155189991, 0.053523823618888855, 0.07255018502473831, 0.10430021584033966, -0.038835618644952774, -0.06794978678226471, -0.06979812681674957, 0.0610855333507061, 0.04498216137290001, 0.11517520248889923, -0.06099487096071243, 0.007259206846356392, -0.13097307085990906, -0.06921132653951645, 0.08185314387083054, 0.010118285194039345, -0.042726822197437286, 0.05489451438188553, -0.04060354083776474, 0.08276639878749847, -0.006390073802322149, 0.060524553060531616, 0.0801885724067688, 0.00947202742099762, -0.10963352769613266, -0.1897667944431305, 0.036469243466854095, 0.10061068832874298, 0.004217829555273056, 0.04222480207681656, 0.11151935160160065, -0.0027067679911851883, 0.07325631380081177, 0.0920284241437912, 0.049315664917230606, -0.023507962003350258, -0.027483010664582253, -0.0014884215779602528, -0.17140212655067444, -0.0606788694858551, 0.007418173830956221, -0.014897644519805908, -0.021134737879037857, -0.10449627786874771, 0.07687495648860931, -0.020433062687516212, -0.045245569199323654, -0.11754672229290009, 0.01583445444703102, -0.12528198957443237, -0.0139684546738863, 0.05288074165582657, -0.044363077729940414, 0.11880044639110565, -0.014728604815900326, -0.06638374924659729, -0.06706066429615021, -0.042019281536340714, 0.03974758833646774, -0.1324266493320465, 6.708577116869504e-33, -0.08478981256484985, -0.03377228230237961, -0.07015465945005417, -0.12234701961278915, -0.057330187410116196, -0.01836456172168255, -0.14746320247650146, -0.0376119539141655, -0.0055863261222839355, 0.16295969486236572, 0.04654878377914429, 0.20494607090950012, 0.054850708693265915, 0.035625286400318146, -0.0598246306180954, -0.13226477801799774, 0.02172161638736725, 0.03857994079589844, 0.007916724309325218, -0.1216827929019928, -0.0469808466732502, 0.02913152612745762, -0.03938763961195946, -0.08676912635564804, -0.10119912773370743, 0.04481570050120354, 0.027998603880405426, 0.06684725731611252, -0.14704611897468567, 0.04476490616798401, 0.034363988786935806, 0.08829911053180695, -0.01112077571451664, -0.09054572135210037, 0.03348090499639511, -0.04474753141403198, 0.029269561171531677, -0.11588408797979355, 0.02558881603181362, -0.10256380587816238, -0.09322666376829147, 0.030223924666643143, -0.15734677016735077, -0.07389496266841888, 0.012573769316077232, -0.010929947718977928, -0.07074163854122162, -0.10504186153411865, -0.11640848219394684, 0.0063469987362623215, -0.01649874821305275, 0.09742824733257294, 0.08061948418617249, -0.03735348954796791, -0.004952230025082827, 0.06622755527496338, 0.028886590152978897, -0.1385534405708313, -0.01638256385922432, 0.03299035504460335, 0.05648774281144142, 0.07828629016876221, 0.029329907149076462, -0.028895443305373192, -0.07696028053760529, 0.06358073651790619, -0.08891619741916656, 0.0889148861169815, -0.08087906241416931, 0.10882629454135895, 0.012746772728860378, 0.09685133397579193, 0.016560282558202744, -0.11815431714057922, 0.07911607623100281, 0.004966329783201218, 0.05335889011621475, 0.111168272793293, -0.0022317259572446346, -0.030368763953447342, -0.03325366973876953, -0.12093399465084076, 0.061751797795295715, 0.043727971613407135, -0.01656186953186989, -0.08238735795021057, -0.018492290750145912, -0.09608183801174164, -0.20556485652923584, -0.04343623295426369, -0.025113951414823532, -0.04581784829497337, -0.028187338262796402, 0.17893564701080322, -0.024063117802143097, -7.448492035994593e-33, -0.10215231776237488, 0.05538643151521683, -0.09721232950687408, 0.047732170671224594, 0.030713221058249474, 0.06322057545185089, 0.0819789469242096, -0.09457673877477646, -0.08839656412601471, -0.028551548719406128, 0.06925539672374725, 0.025963224470615387, -0.19123104214668274, 0.06970636546611786, -0.022941889241337776, -0.06293649226427078, 0.05926539748907089, 0.057024531066417694, -0.0198591910302639, -0.07214688509702682, 0.08211041986942291, 0.20300604403018951, -0.21570879220962524, 0.06750386953353882, -0.036246057599782944, 0.06875748932361603, -0.006318608298897743, 0.08744779229164124, -0.07687585055828094, -0.05027482658624649, -0.02014063484966755, -0.0004962915554642677, -0.0574638657271862, -0.007792038843035698, -0.10459941625595093, 0.09151388704776764, 0.07469040155410767, -0.1040145605802536, -0.0323449969291687, 0.06402155756950378, 0.08917929232120514, 0.0703665167093277, 0.16351309418678284, -0.135062113404274, 0.011838235892355442, 0.08769923448562622, 0.07271777093410492, 0.05950173735618591, 0.13369591534137726, 0.19726717472076416, 0.17624454200267792, 0.0842975452542305, -0.030020803213119507, 0.0775073915719986, -0.12086175382137299, 0.04095663130283356, -0.007030922919511795, -0.07429313659667969, -0.09364888072013855, 0.08560499548912048, -0.019564926624298096, 0.06721693277359009, 0.09563449025154114, 0.0015838351100683212, 0.009384427219629288, -0.07133568823337555, -0.004037624225020409, -0.09576790034770966, 0.044391632080078125, -0.06312918663024902, 0.017731403931975365, 0.12952327728271484, 0.01936487667262554, -0.11268695443868637, 0.017126796767115593, 0.06740852445363998, 0.037309400737285614, -0.16410474479198456, -0.02065417729318142, -0.04067924991250038, -0.1201363205909729, 0.01815411075949669, 0.1048533022403717, 0.1305076777935028, -0.1676713526248932, 0.11680193245410919, -0.18202489614486694, 0.10488012433052063, -0.0325545109808445, -0.04864422231912613, -0.023471029475331306, -0.047178275883197784, -0.12078697979450226, -0.07317894697189331, 0.006427505984902382, -9.954065660622291e-08, -0.09473428875207901, -0.07065051794052124, 0.014754114672541618, 0.010695424862205982, 0.10575707256793976, 0.0449146032333374, 0.11383622884750366, 0.023879509419202805, -0.05434230715036392, 0.055579788982868195, 0.21352025866508484, 0.032508254051208496, -0.10143590718507767, -0.04538661986589432, -0.08571891486644745, -0.018239513039588928, -0.07874423265457153, -0.04009723663330078, -0.029950372874736786, -0.1254144310951233, 0.006677096709609032, -0.06801529228687286, 0.14253202080726624, 0.04531826451420784, 0.04921028017997742, -0.10820358991622925, -0.03218736872076988, 0.13335753977298737, -0.056564174592494965, 0.055585186928510666, 0.026232242584228516, 0.09866895526647568, 0.0642833486199379, -0.04474593326449394, 0.08061982691287994, 0.08707605302333832, 0.025112241506576538, 0.04894154518842697, 0.007878338918089867, 0.1282581388950348, 0.010802842676639557, -0.023705171421170235, -0.014127072878181934, 0.05583467334508896, 0.02802061289548874, -0.00776660954579711, 0.02391786500811577, 0.14206743240356445, 0.021545622497797012, -0.07792747765779495, 0.038614824414253235, 0.022656813263893127, 0.030913375318050385, 0.011978261172771454, 0.05827951431274414, 0.006369096226990223, -0.0457705482840538, 0.014586124569177628, -0.029374171048402786, 0.010112233459949493, 0.13126248121261597, -0.10946043580770493, -0.06457328051328659, 0.02538614347577095], "changes": {"1wk": -5.970153790358608, "1mo": 108.95521215175579}}, {"text": "PREMIUM Sector Update: Health Care Stocks Softer in Late Afternoon Trading MT Newswires Wed, Dec 18, 2024, 11:53 PM 1 min read Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index and the Heal PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-12-18T23:53:59", "sentiment": {"score": -0.535358838737011, "confidence": 0.6066777110099792, "probabilities": {"positive": 0.07131887227296829, "negative": 0.6066777110099792, "neutral": 0.32200342416763306}}, "embedding": [-0.059375353157520294, -0.11489309370517731, 0.1305219829082489, 0.21572203934192657, 0.15209639072418213, -0.08432992547750473, -0.0808761790394783, -0.004476155620068312, -0.06814364343881607, -0.04246759042143822, -0.0465102456510067, 0.28470009565353394, -0.06983231753110886, -0.046923160552978516, 0.07227473706007004, -0.026488089933991432, 0.07533560693264008, 0.015486192889511585, -0.11424538493156433, 0.22126832604408264, -0.1910255253314972, -0.05935411900281906, 0.07892487198114395, 0.005962194409221411, 0.15524645149707794, 0.04698072001338005, -0.11232946068048477, -0.01545011531561613, -0.0028109350241720676, -0.0076887886971235275, -0.07942801713943481, -0.13320030272006989, 0.06114106625318527, -0.04585528373718262, -0.07269095629453659, -0.019398458302021027, 0.0895252525806427, 0.08148225396871567, 0.04750189557671547, 0.08525794744491577, 0.11402782052755356, -0.17529015243053436, -0.1236109808087349, 0.08612819761037827, 0.052206024527549744, 0.033910542726516724, -0.05568855255842209, -0.09141113609075546, 0.07557009905576706, 0.029183929786086082, -0.12478843331336975, -0.14857999980449677, 0.015449564903974533, -0.10333725810050964, -0.07055307179689407, -0.02143731340765953, -0.16328002512454987, -0.12579774856567383, 0.04771780967712402, -0.048064205795526505, -0.03446069359779358, -0.12534712255001068, 0.15321746468544006, 0.1404210776090622, -0.005202605854719877, 0.0463995635509491, 0.13777874410152435, 0.14151647686958313, -0.0916106104850769, -0.21769757568836212, -0.04397091642022133, 0.05885094031691551, 0.053900096565485, 0.02672056294977665, 0.06288948655128479, 0.08518431335687637, 0.05568033829331398, -0.08453967422246933, 0.12217194586992264, -0.10898042470216751, 0.034693341702222824, -0.13441160321235657, -0.000443688768427819, 0.07316901534795761, -0.05290451645851135, -0.041660796850919724, -0.007802927866578102, -0.16595900058746338, -0.07582906633615494, -0.22623132169246674, 0.20325347781181335, 0.030472472310066223, 0.011855034157633781, 0.12891258299350739, 0.05305708199739456, -0.023259887471795082, -0.15638650953769684, -0.036730460822582245, -0.2199934870004654, 0.07255157828330994, 0.005943354219198227, 0.08406736701726913, 0.006935600657016039, 0.08958553522825241, 0.002309772651642561, -0.20637109875679016, -0.15294796228408813, 0.08874285221099854, 0.014689897187054157, 0.11076857149600983, 0.025830700993537903, 0.19491684436798096, -0.02129543013870716, -0.15663009881973267, -0.20800164341926575, 0.11587059497833252, -0.08505277335643768, -0.12869149446487427, 0.024425869807600975, 0.0591338686645031, 0.040029074996709824, 0.06130606681108475, -0.22569572925567627, -0.07373467087745667, 0.08396260440349579, 0.1319665014743805, 0.018299605697393417, 1.0608372930586539e-32, 0.09429703652858734, 0.08018079400062561, 0.07031819969415665, -0.14351694285869598, 0.01190360076725483, -0.03487776964902878, 0.08109287917613983, -0.2296399474143982, -0.021135536953806877, -0.07273752242326736, -0.17176386713981628, 0.20748640596866608, -0.016565479338169098, -0.15116465091705322, -0.1752612292766571, -0.32439717650413513, -0.08420420438051224, 0.12507611513137817, 0.02731362171471119, 0.09875701367855072, -0.09519068896770477, -0.07522870600223541, -0.09900602698326111, -0.08635194599628448, -0.14262700080871582, 0.0077021424658596516, 0.12456674873828888, -0.05097562074661255, 0.08385778218507767, 0.04535911604762077, -0.1272193044424057, 0.09305829554796219, -0.019030867144465446, -0.10065943002700806, 0.09723755717277527, 0.05537541210651398, -0.047032054513692856, 0.047490861266851425, 0.04880918189883232, -0.2612086832523346, -0.08089517802000046, 0.014610230922698975, -0.08403735607862473, -0.08720435202121735, 0.09297198802232742, 0.1654481440782547, 0.047294408082962036, -0.17381472885608673, -0.020475944504141808, -0.13630956411361694, -0.07121177762746811, 0.14792661368846893, -0.17072109878063202, -0.0010858153691515326, -0.04357660934329033, -0.08097586035728455, 0.06433870643377304, -0.05608823522925377, -0.06212139129638672, 0.01843400113284588, 0.22345270216464996, 0.07222282886505127, 0.14001616835594177, -0.1693592667579651, -0.1712167114019394, 0.0976099893450737, -0.15532927215099335, 0.0357760451734066, -0.1311025470495224, 0.17622053623199463, 0.21535614132881165, 0.0672290250658989, 0.005067300051450729, -0.0066498578526079655, -0.01283670961856842, 0.09012001752853394, -0.06310929358005524, -0.01511180680245161, 0.07568524032831192, -0.05440247803926468, 0.1298421323299408, 0.06202895939350128, 0.05257951095700264, 0.13834284245967865, 0.0682990700006485, 0.08215022832155228, -0.0394132100045681, 0.08720620721578598, -0.007039853371679783, -0.1521405130624771, -0.23541229963302612, 0.04482182860374451, 0.06826287508010864, 0.09679339081048965, -0.0060830931179225445, -1.5279999804421427e-32, -0.021015021950006485, 0.002650691196322441, -0.09143207222223282, 0.049452636390924454, -0.03946864977478981, -0.09150133281946182, 0.05312018468976021, 0.11577368527650833, 0.1847240924835205, 0.1885693073272705, 0.1488139033317566, 0.02768813818693161, -0.16193242371082306, 0.051542945206165314, 0.07215283066034317, 0.0676143616437912, -0.09033335745334625, -0.05796937644481659, 0.005983192473649979, 0.1395118236541748, 0.0065019153989851475, 0.14277313649654388, -0.071964792907238, 0.4094811677932739, 0.13713552057743073, 0.045470982789993286, 0.04335305467247963, 0.21956850588321686, 0.11625784635543823, -0.21016131341457367, -0.1494656205177307, -0.10017023235559464, -0.0857318565249443, -0.030212590470910072, -0.06864934414625168, -0.03686549887061119, 0.05475788563489914, -0.056707680225372314, -0.0700552836060524, -0.04764002189040184, 0.18258795142173767, -0.1872398853302002, -0.0035206368193030357, 0.12024231255054474, 0.12104512006044388, 0.11017822474241257, -0.0029053869657218456, -0.04727387800812721, 0.056453071534633636, 0.027052100747823715, -0.0174140315502882, 0.05089075118303299, 0.046470385044813156, 0.24828152358531952, -0.13322892785072327, 0.07147373259067535, -0.05230273678898811, -0.046627361327409744, -0.19977062940597534, -0.0721045732498169, -0.0009125013602897525, 0.16529661417007446, -0.20499832928180695, -0.14032340049743652, -0.062290579080581665, 0.013648010790348053, 0.11800447106361389, -0.21170270442962646, 0.004083849489688873, -0.005825822241604328, -0.03225414454936981, -0.11617978662252426, -0.1458488553762436, -0.27303242683410645, 0.10300640016794205, 0.12909556925296783, 0.03044016659259796, 0.010125423781573772, -0.1473556011915207, 0.15337614715099335, 0.08696276694536209, -0.06133748218417168, 0.01618826575577259, -0.035939496010541916, -0.1546381115913391, 0.12695065140724182, 0.0924009382724762, -0.139715313911438, -0.21911931037902832, 0.07329010218381882, -0.1880406141281128, -0.1729826182126999, -0.12257795035839081, 0.09551022946834564, -0.14730578660964966, -1.0052517041003739e-07, 0.16132806241512299, -0.05787072703242302, 0.06857377290725708, -0.0541158989071846, 0.05754130706191063, -0.1569378674030304, -0.1968161165714264, 0.008714676834642887, 0.0908123329281807, 0.24604013562202454, 0.03893541544675827, 0.08461624383926392, -0.006437245290726423, -0.1128755658864975, 0.05144421011209488, -0.019939087331295013, -0.23930886387825012, 0.1403457671403885, 0.009515330195426941, -0.13992854952812195, 0.062432415783405304, 0.031029924750328064, 0.24975547194480896, -0.035262782126665115, 0.05206330493092537, 0.07837377488613129, -0.01511546690016985, -0.11849081516265869, 0.06506270170211792, 0.03592332825064659, 0.008436573669314384, 0.05926045775413513, 0.08108656108379364, -0.08264508843421936, 0.03897134214639664, 0.04316271096467972, 0.09849613904953003, -0.007927524857223034, 0.04992273449897766, 0.054255787283182144, 0.005804912652820349, -0.13018940389156342, 0.028987063094973564, 0.0450318306684494, -0.021228617057204247, -0.07779205590486526, -0.04033145308494568, -0.034486789256334305, 0.21665126085281372, -0.197973370552063, 0.056287750601768494, -0.11550657451152802, 0.11026459187269211, -0.011310244910418987, -0.04875578358769417, 0.10761357098817825, -0.11822723597288132, -0.08860944211483002, -0.23987844586372375, 0.21188896894454956, 0.1267184168100357, -0.28509795665740967, 0.04434389993548393, 0.14573298394680023], "changes": {"1wk": 11.724141474711445, "1mo": 17.586207073735572}}, {"text": "Cognition Therapeutics provided an update on Phase 2 \u2018SHINE\u2019 study analysis TipRanks Tue, Nov 26, 2024, 3:40 PM 1 min read In This Article: CGTX https://www.tipranks.com/news/the-fly/pluri-gets-6-5m-investment-from-alejandro-weinstein-enters-cacao-market Cognition Therapeutics ( CGTX ) provided an update on a biomarker analysis from the Phase 2 \u2018SHINE\u2019 study in mild-to-moderate Alzheimer\u2019s disease. This new analysis focused on plasma samples from all participants who entered the study with lower levels of plasma p-tau2172. Several blood-based measures of Alzheimer\u2019s disease biology were identified that were normalized in CT1812-treated participants compared to the placebo-treated participants. These biomarker changes occurred in concert with a 95% slowing of cognitive decline as measured by ADAS-Cog11 in the same patients. These data provide further evidence that CT1812 may be preserving cognitive function and slowing disease progression by protecting key neurological system. In this new analysis, the Company reported changes in plasma biomarkers that may reflect Alzheimer\u2019s disease pathology. The results demonstrated that individuals who entered the study with plasma p-tau217 below the median experienced a normalization of several key indicators of Alzheimer\u2019s disease progression, including: Reduction in the neuroinflammatory biomarker, GFAP, an emerging biomarker of brain injury; Lowering of the neurodegenerative biomarker, NfL, an indicator of the degree of neurodegeneration; Impact on amyloid biology demonstrated by a reduction in Abeta42 and Abeta40, key proteins implicated in Alzheimer\u2019s disease Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Published first on TheFly \u2013 the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today\u2019s best-performing stocks on TipRanks >> Read More on CGTX: Cognition Therapeutics Reports Promising Q3 2024 Results Cognition Therapeutics reports Q3 EPS (25c), consensus (22c) Cognition Therapeutics sees cash runway into 2Q25 Is CGTX a Buy, Before Earnings? Cognition Therapeutics releases new episode of \u2018Conversations\u2019 podcast View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-11-26T15:40:13", "sentiment": {"score": 0.25606347247958183, "confidence": 0.2910979092121124, "probabilities": {"positive": 0.2910979092121124, "negative": 0.035034436732530594, "neutral": 0.6738676428794861}}, "embedding": [-0.1762867271900177, -0.15963169932365417, -0.009006207808852196, 0.07138264179229736, 0.01158851943910122, 0.07836564630270004, 0.044768791645765305, 0.2488369345664978, 0.09764089435338974, 0.013259870931506157, -0.06704987585544586, 0.14503233134746552, -0.06794999539852142, 0.09982038289308548, -0.05250534042716026, 0.07677065581083298, -0.03817182779312134, 0.08957351744174957, -0.13903310894966125, 0.03954768553376198, -0.026100169867277145, -0.1426847279071808, 0.0663323849439621, 0.1019022986292839, -0.04532935470342636, 0.13964132964611053, -0.06531735509634018, -0.13954156637191772, -0.1548818200826645, 0.05106836557388306, 0.0695527121424675, 0.07280118763446808, -0.010126901790499687, 0.007129449397325516, -0.08231637626886368, -0.09267690777778625, -0.21347421407699585, 0.06297194957733154, -0.09827063232660294, -0.14899222552776337, 0.045605383813381195, 0.006651496514678001, -0.10562486946582794, -0.04552352800965309, 0.053338419646024704, -0.17560729384422302, 0.015305383130908012, 0.030255567282438278, -0.0789816826581955, 0.040528178215026855, -0.1555473655462265, 0.029685577377676964, -0.12338344752788544, 0.11640401184558868, 0.019034575670957565, 0.17507553100585938, -0.10630040615797043, -0.13815805315971375, 5.505152512341738e-05, 0.03324304148554802, -0.0691082775592804, -0.08602553606033325, 0.09574152529239655, -0.04873145744204521, 0.12481102347373962, -0.0129319466650486, -0.003470540279522538, 0.01032201386988163, -0.12724363803863525, -0.055970605462789536, 0.030369294807314873, 0.00892065279185772, 0.05613765865564346, 0.014875557273626328, 0.02267521433532238, 0.13960318267345428, -0.07031644880771637, 0.042100246995687485, 0.06180104240775108, -0.2369024157524109, 0.13970300555229187, 0.09353142976760864, 0.0884753093123436, 0.08456169813871384, 0.23812086880207062, -0.05527474731206894, 0.1032206118106842, 0.16727480292320251, -0.030457880347967148, 0.01827945187687874, 0.060005079954862595, -0.08175216615200043, -0.08157733827829361, 0.08413548022508621, 0.03063315898180008, -0.044345758855342865, -0.0021898942068219185, 0.02163568325340748, -0.03089120425283909, 0.0023210574872791767, -0.009623308666050434, 0.10061123967170715, -0.07284600287675858, -0.14166609942913055, -0.05189996585249901, 0.046896062791347504, 0.02755170315504074, 0.009782738983631134, 0.0765300765633583, 0.06930548697710037, 0.0010328684002161026, 0.078531414270401, 0.011015395633876324, 0.027264975011348724, -0.05564676970243454, 0.12750472128391266, -0.09013692289590836, 0.07042963802814484, 0.23487882316112518, 0.0794563964009285, 0.12055736035108566, -0.06273873895406723, 0.09629000723361969, 0.011939547955989838, -0.029982153326272964, 0.12935996055603027, -0.09963899105787277, 1.132778502418138e-32, -0.09077763557434082, -0.038667287677526474, -0.06458073109388351, 0.02595357596874237, 0.044174134731292725, -0.09737531840801239, -0.0659165009856224, -0.09839437156915665, -0.08661835640668869, -0.050946250557899475, -0.001153376535512507, 0.0545082651078701, -0.006570417433977127, 0.2041606605052948, -0.008796502836048603, -0.03609529882669449, 0.008149631321430206, -0.004996458999812603, 0.07612986117601395, -0.10817605257034302, 0.06902897357940674, 0.008887674659490585, -0.12334642559289932, 0.013096490874886513, 0.03848307952284813, 0.01617424748837948, -0.1967875361442566, 0.06944067776203156, -0.06708341836929321, 0.043123096227645874, -0.1387307345867157, -0.008111508563160896, -0.07950443029403687, -0.1541680544614792, -0.07510405778884888, -0.04219973087310791, -0.034713003784418106, -0.16464203596115112, -0.09170444309711456, -0.0008626999333500862, 0.10005062818527222, -0.0042442437261343, -0.16900664567947388, -0.07600362598896027, -0.009203167632222176, -0.08181027323007584, 0.05144204944372177, 0.054014526307582855, -0.08807428926229477, 0.06272059679031372, -0.05410992354154587, -0.06818639487028122, 0.04447008669376373, -0.00019196746870875359, -0.1551368236541748, -0.007377055007964373, -0.10581694543361664, -0.13701875507831573, 0.1205316111445427, -0.003822837956249714, 0.11007360368967056, 0.12577448785305023, -0.1459716558456421, -0.04944941774010658, -0.078590989112854, 0.0766228586435318, 0.0367560014128685, 0.011864293366670609, -0.12221743166446686, 0.1217888742685318, 0.06480048596858978, -0.017412660643458366, 0.22608248889446259, 0.10423889011144638, 0.08050858974456787, -0.07388661056756973, 0.054030030965805054, 0.07875566929578781, -0.03058883175253868, -0.175110325217247, 0.024403855204582214, -0.05621076375246048, -0.05996769294142723, 0.10236598551273346, -0.03060869313776493, 0.06599940359592438, 0.07251191884279251, 0.0023185759782791138, -0.18403248488903046, -0.11999844759702682, 0.1109967902302742, 0.0782223716378212, 0.01809116080403328, 0.13003577291965485, -0.15219448506832123, -1.1935161485883317e-32, -0.17709553241729736, -0.06108873337507248, -0.040530573576688766, -0.09554004669189453, -0.023090271279215813, 0.09906988590955734, 0.09831053763628006, -0.11640413105487823, 0.09287966042757034, -0.25475627183914185, 0.10169953107833862, 0.03640618175268173, -0.06714121997356415, 0.004946851637214422, -0.001290739281103015, -0.017037641257047653, -0.1446840763092041, 0.052139762789011, 0.0443965345621109, -0.05019223690032959, 0.08938343077898026, 0.23849770426750183, -0.11289723217487335, 0.23718224465847015, 0.020234502851963043, 0.10783548653125763, 0.15942980349063873, 0.13337992131710052, 0.05214586481451988, 0.07496348768472672, -0.07719546556472778, 0.10235743224620819, -0.18580515682697296, 0.012095795944333076, -0.0901084765791893, -0.056017354130744934, 0.1577926129102707, -0.2361057996749878, -0.1641845554113388, 0.05174968019127846, 0.11401331424713135, 0.12780478596687317, 0.015248725190758705, -0.011095171794295311, 0.11398258805274963, 0.0840914398431778, 0.1185697689652443, 0.002294745296239853, 0.07904618978500366, 0.05875261873006821, 0.08460865914821625, 0.010334296151995659, -0.03704708814620972, -0.025609828531742096, -0.05749077349901199, -0.08902500569820404, 0.035109225660562515, -0.15856429934501648, -0.08715085685253143, -0.07985637336969376, -0.10037027299404144, 0.0803348571062088, 0.052842505276203156, 0.08268138766288757, 0.1352865844964981, 0.058258313685655594, 0.08974843472242355, 0.11131048202514648, -0.036649368703365326, -0.0027861297130584717, -0.09895883500576019, 0.006381368264555931, 0.030682861804962158, -0.1039973646402359, 0.10781429708003998, 0.133173868060112, -0.08859249949455261, 0.04398138448596001, -0.02414313703775406, -0.09451207518577576, -0.0903528481721878, -0.053050585091114044, -0.03271499648690224, -0.05054289102554321, -0.07683317363262177, -0.010201270692050457, -0.08061594516038895, 0.013035341165959835, 0.02085249312222004, -0.02915319986641407, -0.08720440417528152, -0.1976102739572525, -0.09842151403427124, 0.02581186592578888, -0.12764546275138855, -9.992020011395653e-08, 0.08578422665596008, -0.07408975064754486, 0.00464982446283102, -0.06874946504831314, 0.1270405501127243, -0.03746252506971359, -0.021475505083799362, 0.12045955657958984, 0.02387099340558052, 0.05606432631611824, 0.05316220968961716, 0.15154993534088135, -0.142299622297287, 0.008140338584780693, -0.0919230729341507, 0.062471162527799606, -0.07547832280397415, 0.0046380190178751945, -0.0729360356926918, -0.13038842380046844, 0.032171592116355896, 0.1209150031208992, 0.095181904733181, -0.09901051223278046, 0.015631917864084244, -0.0873040035367012, 0.1297350525856018, 0.12047996371984482, -0.0032269698567688465, -0.1787032186985016, -0.0743827223777771, 0.022461602464318275, 0.0351557731628418, 0.03395582363009453, 0.11677256226539612, -0.03665595129132271, 0.18617716431617737, 0.05690282583236694, -0.023167259991168976, 0.18787655234336853, -0.010744186118245125, -0.12210085988044739, -0.04650376737117767, -0.03667734935879707, 0.10415017604827881, 0.009896489791572094, -0.0625760555267334, -0.036597512662410736, 0.041931021958589554, -0.13947483897209167, 0.03338623046875, 0.16064780950546265, -0.0008796779438853264, -0.06017577648162842, -0.1503937542438507, 0.053880587220191956, -0.125681072473526, 0.019611947238445282, 0.05141913518309593, -0.2691706120967865, 0.23300951719284058, -0.017777692526578903, 0.05694245174527168, 0.10853175073862076], "changes": {"1wk": -1.2345667202249964, "1mo": 60.0}}, {"text": "We're A Little Worried About Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Rate editorial-team@simplywallst.com (Simply Wall St) Fri, Dec 13, 2024, 2:53 PM 4 min read In This Article: CGTX There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. Given this risk, we thought we'd take a look at whether Cognition Therapeutics ( NASDAQ:CGTX ) shareholders should be worried about its cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). Let's start with an examination of the business' cash, relative to its cash burn. See our latest analysis for Cognition Therapeutics Does Cognition Therapeutics Have A Long Cash Runway? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at September 2024, Cognition Therapeutics had cash of US$22m and no debt. Looking at the last year, the company burnt through US$26m. That means it had a cash runway of around 10 months as of September 2024. That's quite a short cash runway, indicating the company must either reduce its annual cash burn or replenish its cash. You can see how its cash balance has changed over time in the image below. NasdaqGM:CGTX Debt to Equity History December 13th 2024 How Is Cognition Therapeutics' Cash Burn Changing Over Time? Cognition Therapeutics didn't record any revenue over the last year, indicating that it's an early stage company still developing its business. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is trending over time. With the cash burn rate up 23% in the last year, it seems that the company is ratcheting up investment in the business over time. However, the company's true cash runway will therefore be shorter than suggested above, if spending continues to increase. While the past is always worth studying, it is the future that matters most of all. So you might want to take a peek at how much the company is expected to grow in the next few years . Can Cognition Therapeutics Raise More Cash Easily? Since its cash burn is moving in the wrong direction, Cognition Therapeutics shareholders may wish to think ahead to when the company may need to raise more cash. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash and fund growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations. Story Continues Since it has a market capitalisation of US$20m, Cognition Therapeutics' US$26m in cash burn equates to about 127% of its market value. That suggests the company may have some funding difficulties, and we'd be very wary of the stock. So, Should We Worry About Cognition Therapeutics' Cash Burn? We must admit that we don't think Cognition Therapeutics is in a very strong position, when it comes to its cash burn. Although we can understand if some shareholders find its increasing cash burn acceptable, we can't ignore the fact that we consider its cash burn relative to its market cap to be downright troublesome. Once we consider the metrics mentioned in this article together, we're left with very little confidence in the company's ability to manage its cash burn, and we think it will probably need more money. Taking a deeper dive, we've spotted 7 warning signs for Cognition Therapeutics you should be aware of, and 3 of them are potentially serious. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies with significant insider holdings, and this list of stocks growth stocks (according to analyst forecasts) Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-12-13T14:53:47", "sentiment": {"score": -0.0171513631939888, "confidence": 0.06942082196474075, "probabilities": {"positive": 0.05226945877075195, "negative": 0.06942082196474075, "neutral": 0.8783097267150879}}, "embedding": [0.0013696374371647835, 0.0006490526720881462, 0.0359656922519207, -0.02444271184504032, 0.019095350056886673, -0.036017708480358124, 0.10776694864034653, 0.05485863238573074, 0.16209006309509277, 0.1417180597782135, -0.017262304201722145, 0.0450461208820343, -0.0701608955860138, 0.042871423065662384, -0.09807819873094559, -0.05285312980413437, -0.09619122743606567, -0.010141164064407349, -0.10137958079576492, 0.14692656695842743, 0.0360536091029644, -0.07034063339233398, -0.007405172102153301, 0.09947589039802551, 0.02984403818845749, 0.0401248075067997, -0.11326586455106735, -0.026431908831000328, -0.12402762472629547, -0.012570214457809925, 0.05157466605305672, 0.23149023950099945, 0.08667141944169998, -0.0009234733879566193, 0.015316423960030079, 0.012797772884368896, -0.05208325758576393, 0.16835333406925201, -0.0018866965547204018, 0.007789724972099066, -0.1133967787027359, -0.03118686005473137, -0.02231336198747158, 0.002035914920270443, -0.004726088605821133, -0.17136913537979126, 0.05523274466395378, -0.06294471770524979, -0.1009199246764183, 0.0983457937836647, -0.09634938091039658, -0.02104012481868267, 0.0255044624209404, 0.0800919234752655, 0.0012454753741621971, 0.052839651703834534, -0.031041882932186127, -0.022892722859978676, -0.12735716998577118, -0.0699690729379654, 0.011859038844704628, -0.018234487622976303, 0.040776289999485016, -0.03525432571768761, 0.11442878842353821, 0.09803277999162674, 0.06831248104572296, 0.043100785464048386, -0.04556235298514366, -0.051646165549755096, 0.11090684682130814, -0.0680692195892334, -0.00533507764339447, -0.11171913146972656, -0.0816546082496643, 0.13231706619262695, 0.09006946533918381, 0.13282465934753418, 0.10397817194461823, -0.20033523440361023, 0.12218345701694489, 0.10268743336200714, 0.02475539781153202, -0.03922303393483162, -0.08425073325634003, 0.029741814360022545, 0.1428990662097931, -0.023502696305513382, 0.07228463888168335, 0.09120798856019974, 0.052440814673900604, -0.04693565145134926, -0.045627377927303314, -0.00699846725910902, 0.008686928078532219, -0.027181241661310196, -0.03488431125879288, 0.06411689519882202, 0.05689108744263649, 0.020013442263007164, 0.12147028744220734, 0.16846397519111633, -0.09275978803634644, -0.13467171788215637, 0.04279152676463127, -0.047925498336553574, 0.006463485769927502, -0.014510334469377995, 0.06842590868473053, 0.003989821299910545, -0.07790370285511017, 0.12762589752674103, -0.08968670666217804, 0.008651516400277615, 0.05363897234201431, 0.10638394951820374, -0.19915765523910522, -0.019662335515022278, 0.10004286468029022, 0.01872342824935913, 0.14652355015277863, 0.12990790605545044, -0.007206875830888748, -0.023312993347644806, -0.03429661691188812, -0.03454001247882843, -0.06238371878862381, 1.1153439375487264e-32, -0.0895036980509758, 0.0037275590002536774, 0.026113901287317276, -0.009762130677700043, 0.01681099273264408, -0.03230505809187889, -0.03208116441965103, 0.04289644956588745, -0.05255169793963432, 0.00795257743448019, -0.06605440378189087, 0.1084752157330513, 0.0394117645919323, -0.02391311153769493, -0.024001874029636383, -0.012502994388341904, -0.15640699863433838, -0.0390213280916214, 0.08654086291790009, -0.16541488468647003, -0.04763271287083626, 0.012318583205342293, -0.04175226390361786, -0.04525240510702133, 0.024766679853200912, -0.07984205335378647, -0.14691929519176483, 0.037345144897699356, -0.042174436151981354, 0.030566096305847168, -0.02543622814118862, 0.06913352012634277, -0.023211095482110977, -0.1312217265367508, -0.008037091232836246, -0.03277752920985222, 0.03621799126267433, 0.01385531947016716, 0.07962074875831604, -0.016425495967268944, -0.017705082893371582, 0.043051496148109436, -0.0022724177688360214, -0.005144127644598484, -0.015970861539244652, -0.011178852058947086, 0.016698051244020462, 0.004345127381384373, -0.060152217745780945, 0.0406680554151535, 0.04519302025437355, 0.014215804636478424, 0.05521053448319435, -0.0805182009935379, -0.044439442455768585, 0.051675304770469666, -0.04104248434305191, -0.12070022523403168, 0.02637370489537716, 0.0724635049700737, 0.12370772659778595, 0.07673020660877228, -0.10496462136507034, 0.0824141651391983, -0.1811823546886444, 0.26475515961647034, -0.004148954525589943, -0.0065546538680791855, -0.014490027911961079, 0.04612912982702255, -0.0479714497923851, -0.01948975957930088, 0.09509522467851639, -0.04264270141720772, 0.025617823004722595, -0.048453934490680695, 0.04128265753388405, 0.057343728840351105, -0.10152064263820648, 0.06516711413860321, -0.04452631250023842, -0.12131628394126892, 0.029595062136650085, 0.028893880546092987, 0.028835739940404892, -0.06867141276597977, 0.10418520867824554, -0.09430111944675446, -0.1007097139954567, 0.02690126746892929, -0.061783865094184875, -0.07766115665435791, -0.012734891846776009, 0.17254112660884857, -0.004188094288110733, -9.523855965046143e-33, -0.03706638514995575, 0.04300592094659805, -0.006208719220012426, -0.040961671620607376, 0.010395507328212261, -0.08707530796527863, 0.10834230482578278, -0.034662049263715744, -0.061452724039554596, -0.07053973525762558, -0.046255551278591156, -0.008692564442753792, -0.18403741717338562, 0.1702616959810257, -0.06057509034872055, -0.06133906543254852, 0.09820046275854111, -0.057120420038700104, -0.07936699688434601, -0.040039148181676865, -0.04204680025577545, 0.22962751984596252, -0.15809202194213867, 0.003409331664443016, -0.08023899048566818, 0.1526602804660797, -0.04900158941745758, 0.08658114075660706, -0.007292881608009338, -0.07510420680046082, -0.04086131229996681, 0.059249307960271835, -0.15047681331634521, 0.02661871165037155, -0.017928002402186394, -0.12446040660142899, 0.03199908137321472, -0.18622617423534393, -0.043249309062957764, -0.0756981372833252, 0.059737250208854675, 0.07877937704324722, -0.059171322733163834, 0.03276638314127922, 0.09469322115182877, -0.0899265930056572, 0.022762387990951538, -0.02943517081439495, 0.22302591800689697, 0.18149298429489136, 0.14769116044044495, -0.04583257809281349, -0.03523898869752884, 0.06309732049703598, -0.05886891484260559, 0.10441428422927856, 0.06551677733659744, -0.14754337072372437, -0.09824948012828827, -0.010695039294660091, 0.016411755234003067, 0.05638181418180466, 0.003550121560692787, 0.08983564376831055, 0.015583336353302002, 0.019907472655177116, 0.029819104820489883, 0.003950037062168121, -0.02187139354646206, 0.014864515513181686, -0.06577479839324951, 0.07370058447122574, -0.1028803288936615, -0.11510558426380157, 0.040219664573669434, 0.2668958604335785, -0.06584876030683517, -0.1105400025844574, -0.03142235055565834, -0.10185150802135468, -0.050636254251003265, -0.0915553942322731, 0.1079048365354538, 0.03740983456373215, -0.06917805969715118, 0.048319801688194275, -0.07919153571128845, -0.10647469758987427, -0.06361266225576401, 0.023163145408034325, -0.05243929848074913, -0.2510993182659149, -0.08920532464981079, -0.061958298087120056, -0.03624679148197174, -1.0011314799385218e-07, -0.07524023950099945, 0.032046206295490265, 0.022053934633731842, 0.022014055401086807, 0.1798485368490219, -0.07876107841730118, 0.1290963590145111, 0.039927832782268524, 0.024982020258903503, 0.10848793387413025, 0.1187526285648346, 0.1446177363395691, -0.12617114186286926, 0.12277378141880035, -0.16412511467933655, 0.025269396603107452, -0.13983625173568726, -0.054057855159044266, -0.09089630842208862, -0.07913321256637573, 0.021978724747896194, 0.019418369978666306, 0.03869358450174332, 0.029005154967308044, 0.02258956804871559, -0.13555574417114258, 0.00894606951624155, 0.18179577589035034, 0.006727844476699829, 0.011154653504490852, 0.04474493861198425, 0.015642262995243073, 0.01883234642446041, 0.02973307855427265, 0.09669511765241623, -0.2095731943845749, 0.06787426024675369, 0.08152678608894348, -0.034241944551467896, 0.14450931549072266, -0.06378977000713348, -0.04068460687994957, 0.04107152298092842, -0.014373664744198322, 0.05900045856833458, -0.19117486476898193, -0.2329922616481781, 0.08308705687522888, 0.020401638001203537, -0.1029946506023407, 0.1920785903930664, 0.04128137230873108, -0.009900601580739021, 0.08423943817615509, 0.07836326956748962, -0.08034370839595795, -0.04000907391309738, 0.13078497350215912, -0.1591014564037323, -0.013966996222734451, 0.07498308271169662, -0.11872795224189758, 0.08839910477399826, 0.006990270689129829], "changes": {"1wk": 32.63598806360839, "1mo": 59.205021155285195}}, {"text": "Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies Cognition Therapeutics, Inc. Wed, Dec 18, 2024, 3:22 PM 7 min read In This Article: CGTX Cognition Therapeutics, Inc. - Improvements Across Measures of Behavior, Function, Cognition and Movement - - Expediting Plans to Advance CT1812 into Late-Stage Trials - - Full Results to be Presented at International Lewy Body Dementia Conference (ILBDC) - -\u00a0Cognition Therapeutics and Dr. Galvin, a Principal Investigator, Will Host a Conference Call at 8am ET on December 18 to Review the Topline Data - PURCHASE, N.Y., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced topline results from the exploratory Phase 2 \u2018SHIMMER\u2019 study demonstrating CT1812 produced strong therapeutic responses across behavioral, functional, cognitive, and movement measures in patients with dementia with Lewy bodies (DLB). \u201cThe results from this exploratory Phase 2 trial demonstrated CT1812 could have a meaningful, positive impact on DLB patients across multiple measures of cognitive, behavioral, movement, and functional performance. DLB is a multifactorial disease where patients experience a constellation of symptoms, and the results of this study suggest CT1812 holds promise for DLB patients and their care providers,\u201d stated James E. Galvin, MD, MPH, director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine and a principal investigator in the SHIMMER study. \u201cI believe the SHIMMER topline results are both exciting and very promising, and I am looking forward to working with the team at Cognition as they determine the appropriate next steps for CT1812.\u201d Designed as a signal-finding study, the SHIMMER Phase 2 study enrolled 130 patients with mild-to-moderate DLB who were randomized to receive one of two oral doses of CT1812 or placebo daily for six months. Results indicate the study met its primary endpoint of safety and tolerability, with data showing that DLB patients treated with CT1812 for six months experienced improvement in behavioral, functional, cognitive and movement measures compared to placebo. Importantly, there was an 82% slowing in the total neuropsychiatric inventory (NPI) with particularly strong reduction in anxiety, hallucinations, and delusions in the CT1812 treated arms. In addition, there was a marked reduction in caregiver distress, which suggests a positive impact on the day-to-day lives of those receiving the drug. Participants treated with CT1812 experienced a slowing of decline across all three cognitive measures compared to placebo, including fluctuations in attention which declined by 91%.\u00a0\u00a0 Detailed data will be presented at the International Lewy Body Dementia Conference (ILBDC) in January 2025. Story Continues \u201cThese topline results exceeded our expectations and support the broad potential of CT1812 across neurodegenerative disorders,\u201d stated Anthony Caggiano, M.D., Ph.D. , Cognition\u2019s chief medical officer and head of R&D. \u201cAnalysis of CT1812\u2019s activity in DLB will continue as additional data become available. We look forward to reporting these findings at future medical meetings and reviewing them with the FDA in an end-of-Phase 2 meeting.\u201d \u201cWith the SHIMMER and SHINE results, we are confident in CT1812\u2019s clinical activity given that it has demonstrated broad neurologic and neuroprotective activity in DLB and Alzheimer\u2019s disease,\u201d stated Lisa Ricciardi, Cognition\u2019s president and CEO . \u201cPeople with these diseases, particularly DLB, have few therapeutic options leading to a cascade of symptoms that are painful to the individual and their caregivers. We are eager to continue the development of CT1812 in late-stage clinical trials with the hope of providing a once-daily pill that can treat these devasting neurodegenerative conditions.\u201d Investor Webinar Details: Cognition will review these topline efficacy and safety findings on a webcast conference call at 8:00 a.m. ET today, December 18, 2024. This event will feature a discussion with James E. Galvin, M.D., M.P.H., founding director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine and principal investigator in the SHIMMER study. A live question and answer session will follow formal presentations. The live and archived webcast may be accessed from the Investor Relations section of the Cognition website under News & Events or directly by visiting https://lifescievents.com/event/cogrx/ . James E. Galvin, M.D., M.P.H. is professor of neurology and psychiatry & behavioral sciences, and the Alexandria and Bernard Schoninger Endowed Chair for Memory Disorders at the University of Miami Miller School of Medicine. He is division chief for cognitive neurology, founding director of the Comprehensive Center for Brain Health, and director and principal investigator of the Lewy Body Dementia Research Center of Excellence. Dr. Galvin has authored over 400 scientific publications (h-index=73) and has received over $120 Million in research funding from the National Institutes of Health and Private Foundations. About Dementia with Lewy Bodies (DLB) Dementia with Lewy bodies is the second most common cause of dementia, affecting an estimated 1.4 million Americans. The disease is believed to be caused by a buildup of the protein \u03b1-synuclein, which aggregates in Lewy bodies, which are found within brain neurons. DLB is referred to as a \u201cwhole-body\u201d disease, as it disrupts biological processes affecting autonomic, digestive, cognitive, and motor systems. Varied initial symptoms may include day-to-day fluctuations in alertness level, hallucinations, delusions, movement disorders and REM sleep disorder (acting out dreams while sleeping). Treatments are used off-label to address some of these symptoms but there are currently no disease-modifying therapies approved. About the SHIMMER Study The SHIMMER study ( NCT05225415 ) is an exploratory double-blind, placebo-controlled Phase 2 clinical trial that enrolled 130 adults with mild-to-moderate DLB.\u00a0Participants are assessed throughout the study using the Neuropsychiatric Inventory (NPI) to measure changes in hallucinations, anxiety and delusions; the Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE), which track cognitive performance; the Clinician Assessment of Fluctuation (CAF) to measure the frequency and duration of cognitive fluctuations; and the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III, an objective assessment of parkinsonism. The SHIMMER study is supported by a grant award from the National Institute on Aging of the National Institutes of Health (NIH) totaling approximately $30 million (R01AG071643) and is being conducted in collaboration with James E. Galvin, MD, MPH, director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine and the Lewy Body Dementia Association (LBDA). The SHIMMER study is being conducted at over 30 sites in the United States, many of which are LBDA centers of excellence. Please note, this content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health\u2019s National Institute on Aging. About CT1812 CT1812 is an experimental orally delivered small molecule oligomer antagonist that penetrates the blood-brain barrier and binds selectively to the sigma-2 (\u03c3-2) receptor complex, which is involved in the regulation of key cellular processes. These processes are disrupted by toxic interaction with A\u03b2 or \u03b1-synuclein oligomers, oxidative stress and other disease drivers. The ensuing damage to sensitive synapses can progress to a loss of synaptic function, which manifests as cognitive impairment and disease progression. Participants are currently being recruited in the START study ( NCT05531656 ) of CT1812 in adults with early Alzheimer\u2019s disease; and the MAGNIFY study ( NCT05893537 ) in adults with geographic atrophy (GA) secondary to dry age-related macular degeneration. About Cognition Therapeutics, Inc. Cognition Therapeutics, Inc. , is a clinical-stage biopharmaceutical company discovering and developing innovative, small molecule therapeutics targeting age-related degenerative disorders of the central nervous system and retina. We currently are investigating our lead candidate CT1812 in clinical programs in Alzheimer\u2019s disease, dementia with Lewy bodies (DLB) and dry age-related macular degeneration (dry AMD). We believe CT1812 and our pipeline of \u03c3-2 receptor modulators can regulate pathways that are impaired in these diseases that are functionally distinct from other approaches for the treatment of degenerative diseases. More about Cognition Therapeutics and our pipeline can be found at https://cogrx.com . Forward-Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this press release, other than statements of historical facts or statements that relate to present facts or current conditions, including but not limited to, statements regarding our product candidates, including CT1812, and any expected or implied benefits or results, including that initial clinical results observed with respect to CT1812 will be replicated in later trials and our clinical development plans, the timing of any regulatory submissions, and expectations regarding timing, success and data announcements of current ongoing preclinical and clinical trials are forward-looking statements. These statements, including statements relating to the timing and expected results of our clinical trials involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. In some cases, you can identify forward-looking statements by terms such as \u201cmay,\u201d \u201cmight,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201cplan,\u201d \u201caim,\u201d \u201cseek,\u201d \u201canticipate,\u201d \u201ccould,\u201d \u201cintend,\u201d \u201ctarget,\u201d \u201cproject,\u201d \u201ccontemplate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cforecast,\u201d \u201cpotential\u201d or \u201ccontinue\u201d or the negative of these terms or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond our control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: competition; our ability to secure new (and retain existing) grant funding; our ability to grow and manage growth, maintain relationships with suppliers and retain our management and key employees; our ability to successfully advance our current and future product candidates through development activities, preclinical studies and clinical trials and costs related thereto; uncertainties inherent in the results of preliminary data, pre-clinical studies and earlier-stage clinical trials being predictive of the results of early or later-stage clinical trials; the timing, scope and likelihood of regulatory filings and approvals, including regulatory approval of our product candidates; changes in applicable laws or regulations; the possibility that the we may be adversely affected by other economic, business or competitive factors, including ongoing economic uncertainty; our estimates of expenses and profitability; the evolution of the markets in which we compete; our ability to implement our strategic initiatives and continue to innovate our existing products; our ability to defend our intellectual property; the impact of the COVID-19 pandemic on our business, supply chain and labor force; and the risks and uncertainties described more fully in the \u201cRisk Factors\u201d section of our annual and quarterly reports filed with the\u00a0Securities Exchange Commission and are available at www.sec.gov. These risks are not exhaustive, and we face both known and unknown risks. You should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in a dynamic industry and economy. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties that we may face. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Contact Information: Cognition Therapeutics, Inc. info@cogrx.com Casey McDonald (media) Tiberend Strategic Advisors, Inc. cmcdonald@tiberend.com Mike Moyer (investors) LifeSci Advisors mmoyer@lifesciadvisors.com This press release was published by a CLEAR\u00ae Verified individual. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CGTX", "date": "2024-12-18T15:22:00", "sentiment": {"score": 0.8869192618876696, "confidence": 0.9001427888870239, "probabilities": {"positive": 0.9001427888870239, "negative": 0.013223526999354362, "neutral": 0.08663364499807358}}, "embedding": [0.005662858486175537, -0.0951506495475769, 0.0313815101981163, -0.04679974541068077, -0.16598153114318848, 0.030833104625344276, -0.063993439078331, 0.11495716869831085, 0.026870574802160263, -0.039566684514284134, -0.0486312136054039, 0.13918855786323547, 0.02390071377158165, 0.020709287375211716, 0.04503694921731949, 0.09100867062807083, 0.06689691543579102, 0.12371327728033066, -0.1745239496231079, 0.102924644947052, 0.03215062618255615, 0.0385977141559124, 0.0940776988863945, 0.04756619781255722, -0.21927142143249512, 0.047340765595436096, -0.19693055748939514, -0.20172761380672455, -0.025503041222691536, -0.0182692501693964, 0.1558481752872467, 0.19750221073627472, -0.1504281610250473, 0.010689960792660713, -0.03130802512168884, -0.01242134626954794, -0.1739562302827835, 0.11547385901212692, -0.07260187715291977, -0.16076985001564026, -0.016591358929872513, -0.004888550378382206, 0.051185425370931625, 0.030021514743566513, 0.0027346378192305565, -0.07843205332756042, -0.10769779980182648, -0.05753164738416672, -0.09426885843276978, -0.07612907141447067, -0.07267995923757553, -0.006884995847940445, 0.06510297954082489, 0.12702837586402893, 0.0006282078102231026, 0.13297885656356812, 0.009475002065300941, -0.023830212652683258, -0.026418786495923996, 0.026548709720373154, -0.06663285940885544, -0.024965811520814896, 0.031107036396861076, -0.07785633951425552, 0.08707170188426971, 0.06787244230508804, 0.024955181404948235, -0.07162807881832123, -0.03192673996090889, -0.11280789226293564, -0.007483086548745632, -0.10062087327241898, -0.047107286751270294, 0.08822871744632721, 0.08999711275100708, 0.02708045393228531, 0.008929298259317875, 0.016447480767965317, 0.08984126150608063, -0.20552530884742737, -0.040032222867012024, 0.23796604573726654, 0.050244227051734924, 0.008732869289815426, 0.07870960235595703, -0.060708239674568176, 0.020765993744134903, 0.21812355518341064, -0.05098232254385948, 0.004615490324795246, 0.09171922504901886, -0.07839693129062653, -0.16428957879543304, -0.028974175453186035, -0.050988174974918365, -0.1391240358352661, -0.05419117584824562, 0.0038635414093732834, 0.03199636936187744, -0.018978243693709373, 0.097553551197052, 0.09419044852256775, -0.026698876172304153, -0.05499957501888275, -0.10489004105329514, -0.04742445796728134, 0.17005154490470886, -0.044721800833940506, -0.0009751850739121437, 0.0684003084897995, -0.06311003863811493, -0.007815070450305939, -0.01956653967499733, 0.029444416984915733, -0.06968501210212708, 0.014632163569331169, -0.12749648094177246, 0.14770516753196716, 0.20106683671474457, -0.07937231659889221, 0.12392272055149078, 0.010991224087774754, 0.13630208373069763, -0.022029904648661613, -0.005521021783351898, 0.0010768279898911715, -0.07383759319782257, 9.058280121567867e-33, -0.07373111695051193, -0.05061301589012146, -0.02052624523639679, 0.06498005241155624, 0.07171107828617096, -0.10508589446544647, -0.022173279896378517, -0.04406090825796127, 0.050126392394304276, -0.022799517959356308, -0.03589141368865967, 0.055260103195905685, 0.004429911263287067, 0.19483263790607452, -0.08551809191703796, -0.03993699327111244, -0.04608792066574097, 0.005834112875163555, -0.0709771141409874, 0.006608413532376289, 0.04449533671140671, 0.007300443947315216, 0.02009948156774044, 0.012606313452124596, 0.0009332513436675072, -0.01960059255361557, -0.05926377326250076, 0.10522924363613129, -0.050918277353048325, 0.06003015488386154, -0.14091701805591583, -0.018661540001630783, -0.044238269329071045, 0.013270549476146698, -0.07036371529102325, -0.0012620314955711365, 0.02789781428873539, -0.07421483844518661, 0.007004349958151579, -0.04969204217195511, 0.1353171318769455, 0.04998520761728287, -0.0825263112783432, -0.014958968386054039, -0.05502518266439438, -0.09665953367948532, 0.10371463000774384, -0.09665268659591675, -0.04903193563222885, 0.023261606693267822, -0.007810537703335285, -0.1120164543390274, -0.00396748399361968, -0.08627377450466156, -0.0314989909529686, 0.08865173161029816, -0.08509941399097443, -0.03265559673309326, 0.14040106534957886, 0.06140737235546112, 0.1403319090604782, 0.1668616235256195, -0.08851738274097443, -0.04628055542707443, 0.05540934205055237, 0.08218147605657578, -0.03486690670251846, -0.009972280822694302, -0.054852209985256195, -0.04106893017888069, 0.025746658444404602, -0.05188806354999542, 0.17749401926994324, 0.13753747940063477, 0.16143760085105896, -0.1428268551826477, 0.08464230597019196, -0.0791059136390686, -0.06014194339513779, -0.07061074674129486, 0.08121554553508759, -0.047263503074645996, -0.10545476526021957, 0.04703598469495773, 0.031578756868839264, 0.025197908282279968, 0.06535456329584122, -0.06364916265010834, -0.2519463896751404, 0.028829557821154594, 0.10291390120983124, 0.03685293346643448, 0.03897050768136978, 0.17600977420806885, -0.006030452903360128, -1.2390860972762778e-32, -0.06210622936487198, 0.03439906984567642, -0.01942014880478382, -0.07808493822813034, 0.009350261650979519, 0.01607709750533104, 0.019891373813152313, -0.14042463898658752, 0.12263421714305878, -0.23207762837409973, 0.04116765409708023, -0.10541477799415588, -0.0816858634352684, 0.06208410859107971, -0.025403780862689018, 0.0615854486823082, -0.021446485072374344, 0.03328510373830795, -0.044548265635967255, 0.017596205696463585, -0.012925086542963982, 0.182709738612175, -0.16480855643749237, 0.05197954177856445, -0.04656503349542618, 0.04413536936044693, 0.08608418703079224, 0.08045182377099991, 0.0383528508245945, -0.016321765258908272, -0.020342931151390076, 0.06082645803689957, -0.1430133730173111, -0.05296967178583145, -0.09097295999526978, -0.06632550060749054, 0.14392679929733276, -0.10737700760364532, -0.19708400964736938, -0.06039368733763695, 0.05396532639861107, 0.11659543216228485, 0.07476020604372025, -0.0022507142275571823, 0.023867588490247726, -0.0003287503495812416, 0.020680641755461693, -0.11889779567718506, -0.02514098957180977, 0.118843212723732, 0.0650869756937027, 0.06052158772945404, -0.006580708548426628, -0.05436347424983978, -0.04484576731920242, -0.0617956817150116, 0.04396136850118637, -0.13615229725837708, -0.13296601176261902, -0.143486887216568, -0.0010594725608825684, 0.12871138751506805, -0.11778195947408676, 0.018885551020503044, 0.17071403563022614, 0.14943313598632812, 0.014605751261115074, 0.03378938511013985, -0.0028674406930804253, -0.009248540736734867, -0.15928733348846436, -0.050110820680856705, -0.06598753482103348, -0.16016116738319397, 0.06145770475268364, 0.04532785713672638, -0.0072834980674088, -0.07260923087596893, -0.025515060871839523, -0.11990988254547119, -0.06370960175991058, -0.05345853418111801, -0.028484128415584564, 0.003350535873323679, -0.09209027141332626, 0.06493251770734787, -0.09774844348430634, 0.04148128628730774, -0.011582745239138603, -0.005118055734783411, -0.043428584933280945, -0.06381832808256149, -0.12140898406505585, 0.05549279600381851, -0.02934098243713379, -1.008412340297582e-07, -0.02047085203230381, -0.05591719597578049, 0.0015368219465017319, -0.08795712888240814, 0.021269643679261208, 0.05361101031303406, -0.025507833808660507, 0.08525983989238739, -0.07647716999053955, 0.056458573788404465, 0.09227385371923447, 0.12398898601531982, -0.08047530055046082, -0.08136183768510818, -0.04336916655302048, 0.06415151059627533, -0.022633209824562073, 0.06237942352890968, -0.06532661616802216, -0.09247651696205139, 0.06204172223806381, 0.013311329297721386, 0.07774341851472855, -0.1437879055738449, 0.016652153804898262, -0.044151853770017624, 0.12610751390457153, 0.14482969045639038, -0.045029330998659134, -0.19051650166511536, -0.011182785034179688, 0.07039675116539001, -0.04874514788389206, -0.028143372386693954, 0.13203975558280945, -0.08266280591487885, 0.19354839622974396, -0.022627703845500946, 0.0565035343170166, 0.16060873866081238, 0.030412524938583374, 0.0032148174941539764, -0.009451335296034813, 0.0619068369269371, 0.06671901047229767, -0.08755441009998322, -0.027669306844472885, -0.06012185290455818, 0.05579550191760063, -0.08810172230005264, 0.08176642656326294, 0.1722763180732727, 0.05601019784808159, 0.07687804102897644, -0.07792162150144577, 0.1920795738697052, -0.0629735141992569, -0.03759365901350975, -0.01765267923474312, -0.04615890979766846, 0.14273962378501892, 0.0693185031414032, 0.00286980252712965, 0.000670265406370163], "changes": {"1wk": 11.724141474711445, "1mo": 19.655176843389306}}]